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Abstract 
The DNA damage response protects the genome by executing processes that prevent the 
disruption of normal cell physiology and the inheritance of mutations. BRCA1 is an essential 
tumor suppressor gene that facilitates DNA repair, transcription and plays a more complex role 
in apoptosis. A novel BRCA1 binding protein known as BRAP2/IMP has been characterized as a 
RAS effector with ubiquitin ligase activity and as a cytoplasmic retention protein. BRAP2 is 
conserved in C. elegans, and is known as BRAP-2. Previously, we have shown that BRAP-2 is a 
negative regulator of SKN-1/Nrf2 dependent detoxification gene expression. In addition, brap-2 
deletion mutants experience BRC-1 (BRCA1 ortholog) dependent larval arrest when exposed to 
oxidative stress. BRC-1 function in DNA repair is conserved in the germline, where a loss of 
brc-1 increases apoptosis. Due to the conservation of BRC-1 function in C. elegans and the 
genetic link between BRC-1 and BRAP-2 upon oxidative stress, in this study we examined the 
role of BRAP-2 in DNA damage induced germline apoptosis, C. elegans development and 
germline health. We found that brap-2 mutants display a reduction in DNA damage induced 
germline apoptosis and that apoptosis induced by loss of BRC-1 requires BRAP-2. We also 
found that a loss of PMK-1, SKN-1 and AKT-1 in brap-2 mutants increases apoptosis, indicating 
that a loss of BRAP-2 limits DNA damage induced germline apoptosis and promotes cell 
survival through regulation of the PMK-1 activated SKN-1 oxidative stress response pathway 
and Insulin/Insulin-like growth factor signaling. In addition, brap-2 mutants display defects in 
development, survival, brood size and germline morphology. Taken together, this suggests that 
BRAP-2 is required to promote DNA damage induced germline apoptosis by regulating pro-cell 
survival pathways and that BRAP-2 is required for proper C. elegans growth, development and 
germline health.  
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Chapter 1 
Introduction and Literature Review 
 
1.1 General Introduction 
Programmed cell death (apoptosis), DNA repair and cell cycle arrest are vital pathways 
that protect the genome from the threat of DNA damage and mutations that lead to cellular 
dysfunction and disease (1). The DNA damage response (DDR) activates a network of tumour 
suppressors, enzymes and effector proteins to initiate intricate pathways that faithfully repair 
DNA and protect the cell (Figure 1.1) (2). Sensors, such as the DNA repair proteins RAD51 and 
BRCA1 (Breast cancer susceptibility gene 1) relay signals to downstream transducers (i.e. ATM, 
ATR kinases) and effectors (i.e. p53, CHK1) to coordinate events that determine the fate of a cell 
(2,3).  
These surveillance mechanisms constantly monitor cellular health so that proper survival 
or death pathways are initiated to maintain physiological homeostasis when faced with 
exogenous (i.e. UV, chemicals, toxins) and endogenous forms (i.e. metabolism by-products, 
replication errors) of stress (1,3). However, when the balance of cell death factors outweighs 
those that signal for survival, apoptosis is triggered to eliminate malignancies (4). Without these 
protective measures, inherited or acquired mutations can wreak havoc, disrupting protein 
function and molecular signaling which can lead to apoptosis evasion, uncontrolled growth and 
cancer.  
The genetic pathway for apoptosis activation was first discovered in Caenorhabditis 
elegans, and has since has been studied in models across phyla, including Drosophila, Zebrafish, 
Xenopus, mouse and human cell lines (1,5,6). In C. elegans, observation of apoptosis in both loss 
of function and gain of function mutants lead researchers to determine the conserved genetic 
order for apoptosis activated by CEP-1 (C. elegans p53-like protein 1) (7,8). C. elegans 
2 
 
possesses a high conservation of human disease genes, including those involved in DDR 
pathways (9,10). The C. elegans germline employs conserved mechanisms of cell cycle arrest, 
DNA repair and apoptosis in spatially distinct regions (11). Its simplicity, short life cycle and the 
ability to directly observe developmental and morphological defects caused by mutations, make 
it an ideal model to study gene function and cell signaling pathways (12). These studies provide 
us with a basis for investigation that can be translated to higher conserved model organisms.  
BRCA1 facilitates DNA repair and is involved in transcription, cell cycle arrest and 
apoptosis (13). When BRC-1 (BRCA1 ortholog) function is lost in C. elegans, apoptosis 
increases in the germline (14). In mammalian systems, BRAP2/IMP (BRCA1-associated binding 
protein 2, or BRAP in the HUGO database) was found to bind to the nuclear localization signal 
(NLS) of BRCA1 and has since been characterized as a RAS effector and cytoplasmic retention 
protein (15,16). BRAP2/IMP is predicted to prevent BRCA1 from traveling to the nucleus, yet 
the biological significance of this interaction has not been explored extensively (15). Previous 
work from our lab revealed a genetic interaction between BRC-1 and BRAP-2 (BRAP2 
ortholog) (17). brap-2 mutant animals were found to be hypersensitive to oxidative stress and 
developmentally arrested at the first larval stage (L1), which was dependent on BRC-1 (17). Due 
to the identification of this genetic interaction during oxidative stress and conserved BRC-1 
function, the objective of this project is to determine the role of BRAP-2 in DNA damage 
induced germline apoptosis, as well as determine its potential role in C. elegans development and 
germline health.  
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Figure 1.1: The cellular response to DNA damage 
 
Although depicted as a linear pathway, the response to DNA damage is comprised of a network 
of interacting proteins that sense, transduce and relay signals, in order to execute an appropriate 
response that is dictated by the type and severity of damage sustained. This leads either to 
survival through cell cycle arrest and DNA repair for the resumption of normal cellular function, 
or activation of programmed cell death, all of which serves to preserve genomic stability. Image 
adapted and modifed from (3).  
 
 
 
 
 
4 
 
1.2 Use of Caenorhabditis elegans as a model organism  
1.2.1 Introduction to C. elegans as a model  
 C. elegans is a simple, non-parasitic invertebrate nematode (worm) advantageous for 
molecular genetics research and studies in development, aging, neurological disorders, innate 
immunity and stress response signaling (12,18,19). In 1998, it was the first multicellular 
organism to have its genome completed sequenced, revealing that 40% of human disease genes 
have a C. elegans ortholog (10). This also contributes to great functional similarity both in 
cellular metabolism and disease-related signal transduction cascades, allowing for the genetic 
order of complex pathways and novel genetic interactions to be identified.  
As a hermaphroditic species, C. elegans can self-fertilize producing up to 300 offspring 
per worm, grow up to 1 mm in size and live up to 2 weeks (12). Although in low frequency, 
males can appear spontaneously in the wild type population (0.1-0.2%), due to X chromosome 
non-disjunction (20,21). The C. elegans life cycle is rapid and progresses from a hatched egg, 
through four larval stages (L1-L4) to reach adulthood in 3 days (Figure 1.2A) (12). When worms 
encounter dire stress that threatens their survival, a phase of developmental arrest (dauer) can be 
initiated (Figure 1.2A) (22,23). Worms lie dormant to survive harsh conditions such as an 
increase in temperature, overcrowding, or starvation and once the environment ameliorates, they 
can re-enter the life cycle and continue to develop normally (23). Extensive work has determined 
that inhibition of DAF-16 (the only FOXO ortholog in C. elegans) by the Insulin/Insulin like 
growth factor signaling pathway (IIS) prevents worm entry into dauer, while the sensing of 
pheromones and harsh environmental conditions activate DAF-16 and other parallel pathways 
for the transcription of dauer genes that prepare the worm for arrest and prolonged survival (22–
26).  
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Forward and reverse genetic approaches including: inducing mutations using ionizing 
radiation (IR) or ethyl-methanesulfonate (EMS), or the gene knockdown technique of RNA 
interference (RNAi) respectively, can be employed to study gene function (27). Traditional 
crossing techniques allow for the generation of double mutants to study genetic interactions, 
while transgenic worms can be created to overexpress genes and produce strains with 
transcriptional or translational reporters (12). Genes of interest in C. elegans can now be more 
easily modified to create specific targeted genetic deletions, insertions or reporter tag fusions 
through CRISPR-Cas9 genome editing (28), which is highly advantageous as changes to gene 
and protein expression can be studied in vivo. However, limitations do exist for this model such 
as: it does not possess all the genes, molecular pathways or organ systems (respiratory and 
circulatory) present in mammals; it does not manifest all human disease pathologies; and C. 
elegans cell lines are difficult to maintain (29). 
1.2.2 Anatomy of the C. elegans germline  
In C. elegans, sex is determined by a XX/XO system where the hermaphrodite (viewed as 
female) has two X chromosomes and males have one X chromosome (30). For sexually 
reproducing organisms, meiosis I and II ensures the diploid state after fertilization is restored by 
producing haploid gametes (31). First, the hermaphrodite produces sperm late in larval 
development, which are pushed proximally to complete spermatogenesis and stored in the sperm 
sac (32). In adulthood, the hermaphrodite gonad focuses on oogenesis, where meiosis prophase I 
can be followed visually, progressing sequentially as stages are separated throughout the 
germline by location and can be identified by the changes in nuclear morphology (31).  
The germline is a continuously proliferating, “bi-lobed” structure that develops in a 
spatial-temporal manner (33). Germ cells are held within a common cytoplasm with incomplete 
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cell membranes and each gonad arm empties into a common uterus where fertilized eggs are 
deposited. Proliferation of progenitor mitotic stem cells is maintained in the mitotic zone (MZ), 
due to their proximity to the distal tip cell (DTC) (Figure 1.2B) (34). As mitotic cells move away 
from the DTC, they begin meiosis and enter S phase in the transition zone (TZ) (35). In the TZ, 
chromosomes appear polarized or “crescent shaped” as they line up with their homologous 
partners (lepotene/zygotene stages), and synaptonemal complexes will then form between them 
to hold them together (33,35).  
Germline nuclei then move on to pachytene, a stage that completes synapsis and meiotic 
recombination. Out of several DSBs induced between synapsed homologs by the topoisomerase 
II SPO-11 (SPO11 ortholog), repair by homologous recombination (HR) produces only one 
crossover (CO) between each pair of chromosomes, while the rest are repaired as non-crossovers 
(NCO) (33,36). One successful CO is needed for chiasmata to form between homologs, which is 
necessary for the subsequent condensation and structural changes chromosomes undergo later in 
diakinesis (37). Synaptonemal complexes disassemble in late pachytene located where the gonad 
bends, an area where physiological apoptosis occurs and is commonly referred to as the “death 
loop” (11,33). Here germ cells are at their most feeble and are thought to die if unable to survive 
recombination, or are purposely sacrificed to provide maternal and cytoplasmic factors to 
developing oocytes (11,38). Now at diakinesis, cells leave the common cytoplasm with 6 
homologous chromosome pairs (bivalents) enclosed by their own membrane. Arrested oocytes 
are then fertilized by sperm and embryos are deposited in the uterus until they are ready to be 
expelled through the vulva (Figure 1.2B) (39).  
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1.2.3 Brief overview of the C. elegans germline as a model for the DNA Damage Response 
In addition to studies of meiosis, the C. elegans germline has become a valuable 
experimental system for study of the DDR as an adaptive response to cytotoxic and genotoxic 
insults (11). All three mechanisms for defense: cell cycle arrest, DNA repair and apoptosis are 
highly conserved, and occur in physically separated regions of the germline. Cell cycle arrest 
occurs in the MZ, DNA repair begins in the TZ and occurs throughout pachytene, while 
apoptosis is restricted to late pachytene just before and within the loop region (33). In response 
to DNA damage, arrest is dependent on the activation of the checkpoint genes, MRT-2, HUS-1 
and CLK-2 (40–42). Although not upregulated in response to DNA damage of IR, regulators of 
cell cycle progression such as cyclin dependent kinases (CDKs), cyclin dependent kinase 
inhibitors CKI-1 and CKI-2 (p21 and p27 orthologs), as well as B-cyclins (i.e. cyb-1) are 
required during development (43). Mitotic cell cycle arrest following DNA damage exposure is 
transient, lasting up to 20 hours and is identified by the pronounced enlargement of nuclei which 
can be viewed with DAPI staining, or directly using differential interference contrast (DIC) 
microscopy (44,45).  
DNA repair protects against mutation, genomic instability, chromosomal abnormalities, 
embryonic lethality, increased DNA damage sensitivity, and defects in development (46). In C. 
elegans, somatic cells use the highly error prone “better with errors than dead” approach, of non-
homologous end joining (NHEJ) to repair DSBs, which ligates broken ends of DNA (47,48). In 
the germline, the dominant form of DNA repair is HR and is responsible for repairing DNA 
faithfully by locating a homologous template, to ensure at least one DSB in each of the worm’s 
six chromosomes is repaired to produce a CO for chiasmata formation (47).  
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Germline cells are constantly under threat from internal and external stressors that can 
compromise their resistance and genomic integrity. DNA damage caused by SPO-11 activity or 
stress exposure (i.e. IR) will activate the recruitment of conserved C. elegans DDR sensors to 
process and repair DSB sites. The MRN complex (MRE-11, RAD-50, NBS-1) first arrives to 
process the DSB, followed by nucleases like DNA-2 and EXO-1 that resect DNA strands to 
create single-stranded DNA (ssDNA) (49–51). ssDNA is coated with the replication protein RPA 
and then replaced by RAD-51, that together with structural maintenance proteins and BRC-1 
search for and facilitate homologous template strand invasion (52–54). How exactly the broken 
DNA strand detects its homologous template is unclear, but it is thought that the ssDNA strand 
invades and binds to its nearest complement to complete DNA synthesis and repair (52–54). In 
the end, two outputs are possible: synthesis dependent strand annealing will produce NCOs, 
while the resolution of double Holliday junctions by resolvases such as GEN-1 and SLX-1 will 
generate both CO and NCO products (55,56). Mutations in genes involved in DNA repair can be 
identified by the morphology of oocyte chromosomes arrested in diakinesis (45). They have been 
found to exhibit a range of chromosomal abnormalities such as, increased chromosome number 
(up to 12) seen in rad-51, mre-11 and spo-11 mutants (57,58), chromosome fusions and 
entanglements (48), breaks or fragmentation, as well as bent chromosome axes (59).  
Cell cycle arrest and DNA repair ensure that only cells with uncompromised genetic 
information are inherited, while apoptosis eliminates damaged cells to protect against 
transformation. Activation of intrinsic apoptosis in mammals and the conserved pathway of 
DNA damage induced germline apoptosis in C. elegans will be discussed in the following 
section.  
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Figure 1.2: The C. elegans life cycle and adult germline anatomy  
(A) Illustration of the stages of the C. elegans life cycle at 22°C, adapted and modified from 
Wormatlas. (B) Diagram of adult C. elegans hermaphrodite anatomy. Image adapted and 
modified from (60). Illustration of one enlarged gonad arm with zones labelled to indicate stages 
of meiosis. The gonad bend, is known as the “death loop” where programmed cell death occurs. 
Image adpated and modified from (61).  
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1.3 The intrinsic “mitochondrial dependent” pathway of apoptosis  
1.3.1 Activation of the intrinsic pathway of apoptosis in mammalian systems 
Apoptosis is “cell suicide”, an essential event for tissue homeostasis, morphogenesis and 
the elimination of “self-reactive” or malignant cells that threaten the health an organism (1). 
Apoptosis activation was first discovered in cell fate studies of C. elegans embryogenesis, 
revealing conserved pro-apoptotic genes egl-1 (BH3 ortholog), ced-3 (Caspase 3 ortholog), ced-4 
(APAF1 ortholog), and anti-apoptotic gene ced-9 (BCL2 ortholog) function to activate apoptosis 
in a simple linear genetic pathway (62,7). However, continued research in mammalian systems 
has shown that apoptosis is far more complex and while tightly controlled, is governed by 
fluctuations in the balance between pro-survival and pro-death factors (63).  
Too much, or too little apoptosis can be detrimental and lead to autoimmune disorders, 
neurodegeneration and cancer (64). As a result, apoptosis has been found to be executed by one 
of two main mechanisms: The extrinsic pathway and the intrinsic pathway. The “death receptor” 
or extrinsic pathway of apoptosis, is activated when extracellular ligands such as Fas, TNF-α 
(Tumour necrosis factor), and TRAIL (TNF-related apoptosis-inducing ligand) bind to cell 
surface receptors for the activation and formation of DISC (Death inducing signaling complex) 
(65). DISC contains FADD (Fas associated protein with death domain), an adaptor protein which 
activates caspase 8 for the downstream activation of caspases 3/6/7, cysteine proteases that will 
execute cell death through the breakdown of vital organelles and structural proteins (66,67).  
The “mitochondrial” or intrinsic pathway is governed by the abundance of either pro-
death or pro-survival factors and is dependent on the type and severity of DNA damage (4). This 
pathway is activated in response to DNA damage exposure (i.e. IR, UV), oncogene activation, 
and growth factor removal, in order to eliminate the possibility of cellular transformation and 
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malignancy. The transcription factor p53 is one of the most important tumour suppressors that is 
most frequently mutated in cancer, preventing the transcription of genes that control cell cycle 
arrest, DNA repair and apoptosis (68). Although p53 can increase the expression of extrinsic 
pathway ligands to promote cell death through caspase 8 activation, the p53 transcriptional 
response shows preference for intrinsic apoptosis to eliminate cancer cells (65,69).  
Checkpoint sensors ATM (Ataxia telangiectasia mutated), ATR (Ataxia telangiectasia 
mutated and Rad 3 related), and CHK1/2 (Checkpoint kinase 1/2) as well as prominent stress-
activated protein kinases (SAPK) p38 MAPK and JNK (c-Jun N terminal Kinase), phosphorylate 
stabilize and activate p53 in response to stress (70–72). However, p53 must be able to respond to 
and interpret stimuli from a variety of stressors, and depending on severity must elicit an 
appropriate response of either survival or death, which is apparent by its complex regulation as it 
is also targeted for ubiquitination, sumoylation and neddylation (70). Once active, p53 enters the 
nucleus to increase the transcription of pro-apoptotic factors such as PIG3 (p53 induced gene 3) 
(73), and members of the BCL2 (B-cell CLL/lymphoma 2) family the BH3 domain containing 
genes: Bax, Bid, Puma and Noxa (64).  
The increased production of these pro-apoptotic factors travel to and disrupt 
mitochondrial membranes through anti-apoptotic protein inhibition to facilitate the release of 
pro-death molecules such as AIF (Apoptosis inducing factor) for nuclear fragmentation, Smac 
and Diablo, and most notably cytochrome c from the intermembrane space (74–77). Once in the 
cytoplasm, cytochrome c binds to and interacts with the adaptor APAF1 (Apoptotic protease 
activation factor 1), and promotes its oligomerization (Figure 1.3). APAF1 and activated caspase 
9 form an apoptosome complex which subsequently activates caspases 3 and 7, which will 
degrade cellular proteins (78).  
12 
 
In addition to increasing BH3 domain pro-apoptotic gene expression in response to stress, 
p53 also increases APAF1 transcription, which is believed to help drive apoptosis activation with 
cytochrome c release (79). At the same time, p53 can strengthen the apoptotic decision by 
increasing PTEN (Phosphatase and tensin homolog) gene expression, a PI3K (Phosphoinisotide-
3 kinase) phosphatase which can prevent the downstream activation of AKT (Protein kinase B) 
attenuating cell survival (80). To prevent prolonged p53 activation especially in healthy cells, the 
E3 ubiquitin ligase MDM2 (Mouse double minute 2) targets and ubiquitinates the p53 tumour 
suppressor, promoting its cytoplasmic localization and degradation (81). Thus, when a cell is 
faced with insurmountable DNA damage that cannot be overcome by survival associated 
pathways of DNA repair and cell cycle arrest, increased expression of pro-apoptotic factors will 
activate intrinsic apoptosis to prevent the accumulation of mutations and eliminate the threat of 
malignancy.  
1.3.2 Intrinsic apoptosis is conserved in C. elegans  
During C. elegans embryogenesis loss of function in egl-1, ced-3 or ced-4 genes prevents 
cell death. A loss of ced-9 caused immense cell death leading to inviability, while ced-9 gain of 
function mutants prevented cell death altogether (62,7). From this, egl-1, ced-4 and ced-3 where 
deemed executors of apoptosis while, ced-9 is an essential anti-apoptotic gene. Epistatic studies 
established the conserved linear core apoptotic pathway, where egl-1 inhibits ced-9, ced-9 
inhibits ced-4, and ced-4 is required for ced-3 activation (82).  
 Apoptosis in adult germlines follows the intrinsic pathway and removes approximately 
50% of cells during development (11). There are two forms of apoptosis induction in C. elegans 
that occurs within the “death loop” region, which consists of late pachytene germ cells: (i) 
Physiological apoptosis is CEP-1 (p53-like protein) independent, and is necessary for oogenesis 
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and responds to cytoplasmic stressors such as the collapse of replication forks (11); (ii) DNA 
damage induced apoptosis which is CEP-1 dependent (11,83). In C. elegans, exposure to 
exogenous stressors such as chemicals, toxins and IR is first sensed by the 9-1-1 checkpoint 
proteins: MRT-2, HPR-9 and CLK-2 (40). These proteins are sensors that will relay signals to 
transducer proteins that decide based on damage type and severity whether cell cycle arrest, 
DNA repair, or apoptosis will be activated.  
 The 9-1-1 complex activates ATL-1 (ATR ortholog) and ATM-1 (ATM ortholog) 
transducer kinases to phosphorylate and activate CEP-1 (84,85). Upon activation of CEP-1, it 
increases the transcription of its BH3 only domain target egl-1 and its paralog ced-13, where 
EGL-1 and CED-13 are believed to bind to and inhibit CED-9 to release its inhibition of CED-4 
(86–89). CED-4 can then activate CED-3 to induce apoptosis (Figure 1.3), although recently 
there has been some debate whether CED-9 and CED-4 truly co-localize on mitochondria (90). 
In the “death loop”, cells programmed to die display a characteristic, highly refractive and raised 
“button-like” appearance that can be viewed directly using DIC microscopy (45). Dead cells will 
then express the CED-1 transmembrane protein marker for phagocytosis and are engulfed by 
neighbouring cells (91).  
Similar to mammals, parallel pathways and independent factors can influence the core 
apoptosis pathway. Studies of individual C. elegans DDR related genes have also uncovered its 
own complex world of apoptosis activation, where DNA repair mutants tend to exhibit higher 
levels of germline apoptosis (i.e. brc-1), while DNA checkpoint mutants (i.e. cep-1) exhibit 
lower levels of apoptosis (45). Loss of the E3 ubiquitin ligase EEL-1 (Mule ortholog), KRI-1 
(KRIT1/CCM1 ortholog), SIR-2.1 (SIRT1 ortholog), or meiosis CO genes MSH-4/5 reduce 
germline apoptosis in response to IR and were found to promote apoptosis independently of 
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CEP-1 (92–95). Germline P granule proteins PGL-1/3 have been found to act as apoptosis 
suppressors, where the loss of either pgl-1 or pgl-3 increased both SIR-2.1 and CED-4 co-
localization outside of nuclei, and increased germline apoptosis before and after UV (ultraviolet) 
exposure (94,96).  
In addition, the loss of either of the transcription factors EGL-38 and PAX-2 (Pax2/5/8 
orthologs), reduced ced-9 expression levels and increased germline apoptosis (97). The same was 
observed with a loss of LIN-35 (Retinoblastoma ortholog) in response to starvation stress, 
suggesting that these transcription factors regulate apoptosis apart from CEP-1, by regulating 
ced-9 (98,99). Although an ortholog for the p53 inhibitor MDM2 is not known to be conserved, 
CEP-1 can be negatively regulated by the E3 ubiquitin ligase SCFFSN-1, where fsn-1 (F box 
protein 45 ortholog) mutants’ display increased germline apoptosis induced by ENU (N-ethyl-N-
nitrosourea), increased phosphorylation of CEP-1 and increased CEP-1 transcriptional activity 
(100,101). Also the loss of akt-1 (AKT1 ortholog) of the IIS pathway increases egl-1 and ced-13 
expression, while akt-1 gain of function mutants suppress this enhancement in response to DNA 
damage, indicating that AKT-1 is another potential negative regulator of CEP-1 (102). This 
demonstrates that similar to mammalian systems, the complexity of apoptosis regulation in C. 
elegans is conserved, and in response to DNA damage can occur independently of CEP-1.  
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Figure 1.3: Pathways depicting DNA damage induced germline apoptosis in C. elegans and 
its conservation to mammalian intrinsic apoptosis.  
The pathway for activation of DNA damage induced germline apoptosis in C. elegans is shown 
alongside its respective conserved components in mammalian intrinsic apoptosis. Adapted and 
modified from (78).  
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1.4 BRCA1 is a dynamic tumour suppressor of the DNA damage response 
1.4.1 BRCA1 structure and function in mammalian systems  
BRCA1 is a vital tumor suppressor that participates in several DDR mechanisms 
including DNA repair, transcriptional regulation, cell cycle control and ubiquitination in 
response to DNA damage (103–105). While somatic BRCA1 mutations are rare, loss of BRCA1 
function through germline mutation accounts for 50% of all familial breast cancer cases, is 
associated with an 80% increased lifetime risk of developing ovarian cancer and has been linked 
to prostate cancer (106). The BRCA1 protein contains: a RING (Really Interesting New Gene) 
domain typical of E3 ubiquitin ligases, a NES (Nuclear export signal), a NLS, a coiled-coil, and 
two BRCT (BRCA1 C Terminus) domains which are typically found in proteins associated with 
DNA surveillance (Figure 1.4A) (13).  
BRCA1 becomes a functional ubiquitin ligase when it binds to its heterodimeric binding 
partner and tumor suppressor BARD1 (BRCA1 RING-associated protein 1) (107). To preserve 
genomic integrity, BRCA1 can bind to several distinct complexes to regulate transcription, 
remodel chromatin, as well as participate in protein recruitment to facilitate DNA repair via HR, 
the least error-prone DNA repair system (Figure 1.4C) (108). BRCA1 shuttles into and out of the 
nucleus through the Importin-α /β pathway, and is most commonly detected at DNA replication 
sites (104). In response to DNA damage, BRCA1 is recruited to DSBs and will bind to larger 
functional protein complexes or dimerize with BARD1, which obscures the NES to keep BRCA1 
in the nucleus (109).  
Specifically, in response to IR, DSB sites are initially marked with H2AX (Histone type 
2A phosphorylated) and kinases ATM and ATR are activated. CHK1/2 are direct downstream 
targets of these kinases, who in turn will phosphorylate and recruit BRCA1 and other DNA 
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repair proteins such as RAD51 and the MRN (MRE11, RAD50, NBS1) complex (110). Like 
p53, BRCA1 can be phosphorylated at different sites to direct its function and can be 
ubiquitinated and sumoylated (111). BRCA1 and MRN form a surveillance complex, where 
BRCA1 can regulate MRE11 ssDNA resection for subsequent homologous template invasion 
and repair. While the MRN complex is also involved in NHEJ, the presence of BRCA1 at these 
damage sites indicates a preference for HR (112). Therefore, BRCA1 mutations can lead to 
detrimental effects, ranging from genomic instability, formation of mammary gland tumours and 
cancer, to accelerated ageing (105,113,114).  
Due to the various activities of BRCA1 during the DDR, it plays a more complex role in 
the regulation of apoptosis. Overexpression of BRCA1 is associated with increased apoptosis, 
while mutated BRCA1 has been linked to reduced apoptosis and tumorigenesis (15,115). 
BRCA1 expression can also stabilize p53 to facilitate the transcription of the cell cycle arrest 
gene p21, where a loss of BRCA1 can cause a switch from p53 targeted transcription of survival 
genes to increased expression of apoptosis genes (116,117). However, increased apoptosis has 
been associated with BRCA1 can be cleaved by caspase 3 in response to UV (118). In response 
to IR and growth factor removal, the presence of functional BRCA1 was associated with 
apoptosis induction, and less apoptosis was observed with a mutant form of BRCA1 (118,119). 
However, BRCA1 deficient cells have also been found to succumb to apoptosis more easily 
following IR exposure (120).  
It is thought that the localization of BRCA1 also influences the cell death decision, as 
BARD1 binding and retention of BRCA1 in the nucleus is associated with reduced apoptosis 
(115). Interestingly, after IR exposure BRCA1 has been found to co-localize with BCL2 at 
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mitochondria and it is proposed that this interaction may repress DNA repair by depleting 
BRCA1 nuclear localization, to help facilitate intrinsic apoptosis (121).  
1.4.2 BRCA1 is conserved in C. elegans and is known as BRC-1 
In C. elegans, BRCA1 is functionally conserved and is known as BRC-1. It contains 
similar RING and BRCT domains and centrally located “low complexity regions” or LCR 
domains (Figure 1.4B). LCRs constitute amino acid sequences that contain single amino acids or 
short motif repeats (122). Abundant in eukaryotic proteins, proteins with LCRs tend to have 
many interacting binding partners and Gene Ontology analyses reveal both central and terminally 
located LCRs are common in proteins involved in stress response signaling (123). BARD1 is 
also conserved in C. elegans and is known as BRD-1. Using an Y2H (Yeast 2 Hybrid) assay (and 
subsequently verified in vitro with a pull down assay), the interaction between BRC-1 and BRD-
1 was found to be conserved, where BRD-1 was also found to interact with UBC-9 (Ubiquitin 
conjugating enzyme 9) and RAD-51 (5). 
BRC-1 is vital to the DDR, facilitating HR repair of DSBs during meiosis. A loss of brc-
1 causes an increase in RAD-51 foci persistence in pachytene nuclei, which is indicative of an 
inability to process DSBs (53). A loss of brc-1 causes high levels of CEP-1 dependent germ cell 
death and X-chromosome non-disjunction, leading to an increased incidence of males (14). This 
high apoptosis phenotype has been linked to defective DNA repair in brc-1 mutant animals 
following DNA damage, leaving DSBs unresolved during meiotic recombination which is also 
thought to lead to increased embryonic lethality (45).  
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Figure 1.4: BRCA1 is functionally conserved in C. elegans 
 
(A) Mammalian BRCA1 is 1863 amino acids in length and has a RING (Really interesting new 
gene) domain. It has both a nuclear localization signal (NLS) and nuclear export signal (NES), a 
coiled-coil domain and two BRCT (BRCA1 C terminus) domains. Illustration of protein 
structure was adapted from (13). (B) In C. elegans, the BRCA1 ortholog known as BRC-1 also 
possesses a RING domain, and two “Low Complexity Regions” (LCR). It also has two BRCT 
domains at the C-terminal region but is much shorter in length at 612 amino acids. Protein 
domain structures are not to scale. Structure adapted from SMART. (C) BRCA1 is most well-
known for facilitating DNA repair via HR and also participates in many process of the DDR by 
binding to several complexes. Image of the left adapted and modified from (108,124). Image on 
the right taken and modified from (125). 
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1.5 BRAP2 is a BRCA1 binding protein and potential scaffold for the 
regulation of cell signaling  
BRAP2 was first discovered in a study using an Y2H screen searching for novel BRCA1 
binding partners. The interaction between BRCA1 and BRAP2 was validated, and BRAP2 was 
found to bind to the NLS of BRCA1 (15). BRAP2 has been found to localize to the cytoplasm, a 
result that has been verified in every subsequent study of BRAP2 function. BRAP2 retains 
BRCA1 in the cytoplasm and impedes it from traveling to the nucleus, inferring that BRAP2 
may prevent BRCA1 from performing its DDR associated functions (15). However, analysis of 
the biological implications of the BRCA1/BRAP2 interaction has not been extensively studied.  
 BRAP2 consists of 592 amino acids with the following characteristic domains: A RING 
domain, followed by a ZnF-UBP (Zinc Finger Ubiquitin Protease) domain. These two motifs 
comprise the enzymatic portion of BRAP2 as an E3 ubiquitin ligase. BRAP2 also contains a 
coiled-coiled domain made up of leucine heptad repeats, involved in protein-protein interactions 
(126). At the C-terminal end, a LCR domain is present, which suggests that BRAP2 may play a 
role in regulating stress responses (123) (Figure 1.5A). Following the discovery of the 
BRCA1/BRAP2 interaction, several studies emerged that while verifying its cytosolic 
localization and retention function, also revealed new BRAP2 protein binding partners. BRAP2 
was found to bind to the NLS and prevented the nuclear translocation of viral proteins SV40 
large tumour antigen and ppUL44 (Human Cytomegalovirus DNA Polymerase Processivity 
Factor) (126), as well as the cell cycle inhibitor p21 during monocyte differentiation (127). 
BRAP2 function as an E3 ubiquitin ligase was confirmed, seen with its ability to bind to and 
enhance Lys63 poly-ubiquitination of the protein phosphatase CDC14 (128). BRAP2 is also 
reported in literature as IMP (Impedes Mitogenic Propagation), and was found to bind to KSR1 
(Kinase Suppressor of RAS). BRAP2 was also found to bind to RAS in a GTP dependent 
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manner. Thus in the absence of growth factor activated RAS, it is believed to act as an inhibitor 
of downstream ERK (Extracellular signal related kinase) activation (Figure 1.6) (16,129–131).  
Upon activation of RAS, BRAP2 is auto-ubiquitinated, relieving KSR1 inhibition which 
allows KSR1 to translocate and mediate the formation of the RAF/MEK/ERK complex at the 
plasma membrane for terminal ERK1/2 activation (129). In vivo, BRAP2 was also found to be 
neddylated at Lys432 by the ubiquitin like protein Nedd8 (132). In the same study, in response to 
TNF-α stimulation BRAP2 was found to partly prohibit the nuclear translocation of NF-κB 
(Nuclear factor kappa-light-chain-enhancer of activated B cells) in vitro, attenuating this 
pathway which is critical to survival, the inflammatory response and cell cycle regulation (132).  
 BRAP2 protein expression has been detected in many tissues including lung, kidney and 
brain but is most robustly expressed in mammalian heart and testes (133). This may indicate that 
BRAP2 is important for male germline development. An initial Y2H screen was performed using 
a human testis cDNA library and BRAP2 was found to bind to and inhibit the nuclear 
accumulation of the testis proteins HMG20A, NUMA1 and SYNE2 (134). Another group, 
Fatima et al. (2015) set out to build a BRAP2 interaction network, conducting a similar screen 
and detected another 24 potential testes specific protein binding candidates for BRAP2 
including: APOA1, AKAP3, and the SWI/SNF-related matrix protein SMARCE1. They further 
validated BRAP2 interactions with DNMT1 (DNA Methyltransferase 1) and the AKT protein 
phosphatase PHLPP1 (PH Domain and Leucine Rich Repeat Protein Phosphatase 1). This 
reinforces the importance of BRAP2 as a binding protein and the potential distinct biological 
processes it may regulate. In the same study, when the interaction between BRAP2 and PHLPP1 
in testes was further investigated, BRAP2 was found to act as a scaffold for PHLPP1 and 
retained it in the cytoplasm during spermatogenesis. Taken one step further, with this 
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PHLPP1/BRAP2 interaction it can be predicted that BRAP2 may also indirectly regulate the 
PI3K/AKT pathway, which is known to promote proliferation, cell survival and growth (135). 
Taken together, current literature characterizes BRAP2 as an E3 ubiquitin ligase, a RAS effector, 
as well as a cytoplasmic retention protein that prevents nuclear import. 
1.5.1 BRAP2 is conserved in C. elegans and is known as BRAP-2 
C. elegans possesses a BRAP2 ortholog known as BRAP-2 (Figure 1.5B). The brap-2 
gene is located on chromosome II next to PINK-1 (PINK1 PTEN-induced kinase ortholog). 
PINK1 is a ser/thr (serine/threonine) protein kinase that functions to protect cells from stress 
induced damage to mitochondria, where its loss can lead to a defective oxidative stress response 
and is associated with Parkinson’s disease (136). In addition to its protein domain structure 
which alludes to its potential functional activity, the location of brap-2 next to a gene that is 
involved in the oxidative stress response provides us with a clue to its potential physiological 
importance.  
Previous work from our lab has shown that a mutant form of BRAP-2, the brap-
2(ok1492) (Figure 1.5C) deletion mutant experienced L1 larval arrest that is dependent on BRC-
1 when exposed to low concentrations of paraquat, an oxidative stress inducer (17). This 
indicates that a genetic interaction exists between these two genes during oxidative stress. Our 
lab has also confirmed that BRAP-2 physically interacts with the active form of LET-60 (C. 
elegans RAS ortholog) and KSR-2 (KSR2 ortholog). We also found that brap-2(ok1492) 
mutants exhibit increased levels of both MPK-1 and phosphorylated MPK-1 levels.  This 
indicates that BRAP-2 may display conserved function as a RAS effector in C. elegans.  
Extending previous work investigating the role of BRAP-2 during oxidative stress, our 
lab also demonstrated that brap-2(ok1492) mutants cause a 2.6-fold increase in SKN-1 (Nrf2 
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ortholog) import into intestinal nuclei, as well as increased expression of gst-4 (GST4 ortholog) 
and other SKN-1 dependent phase II detoxification genes (137). This discovery lead our lab to 
conduct a transcription factor specific RNAi screen, which uncovered 20 new potential 
candidates in the regulation of the C. elegans oxidative stress response and longevity. The SKN-
1 transcription factor has been implicated in the regulation of lifespan, and is known as the 
master regulator of the oxidative stress response in C. elegans that upon phosphorylation enters 
intestinal nuclei to activate the transcription of detoxification genes (138). This suggests that 
BRAP-2 may act as a negative regulator of SKN-1, in order to prevent an inappropriate 
detoxification response (137). Yet, similar to the BRCA1/BRAP2 interaction in mammals, the 
role of BRAP-2 and its genetic link to BRC-1 in the DDR and its potential for the protection of 
germline genomic integrity have not yet been addressed.  
 
 
 
 
 
 
 
 
 
 
 
24 
 
 
 
 
Figure 1.5: Protein domain structures of mammalian BRAP2 and C. elegans BRAP-2  
(A) BRAP2 is a 592 amino acid protein with a RING domain, Zinc Finger Ubiquitin Protease 
(ZnF-UBP), leucine heptad repeats that constitute a coiled-coil domain, and a Low Complexity 
Region (LCR). LCR has been detected in proteins associated with stress responses. Domain 
structure adapted from SMART and (133). (B) Full length C. elegans BRAP-2 is conserved and 
possesses a BRAP2 domain, RING domain, ZnF-UBP and leucine heptad repeats (coiled-coil) 
that is predicted to be responsible for protein-protein interactions. It also retains the LCR, 
implicated in stress signaling (17). (C) In this study, we focus on the brap-2(ok1492) gene 
product, where exons 5-8 are deleted in the ok1492 allele which results in the removal of 259 
amino acids at the C-terminal end removing the ZnF-UBP and leucine heptad repeats (17). 
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Figure 1.6: The predicted role of BRAP2/IMP in RAS signaling  
When RAS is inactive, BRAP2/IMP remains bound to and inhibits KSR2, preventing the 
phosphorylation and thus activation of downstream kinases. When the pathway is activated, 
GDP-RAS will be converted to GTP-RAS and bind to BRAP2. BRAP2 degrades by auto-
ubiquitination, releasing KSR2 from inhibition. This is followed by the activation of KSR2 by 
RAS-GTP. KSR2 facilitates the phosphorylation of MEK and ERK by RAF. Active ERK can 
then phosphorylate nuclear and cytoplasmic destined substrates to elicit both transcriptional and 
cellular changes, respectively. Image adapted and modified from (139).  
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1.6 Conserved C. elegans cell signaling pathways relevant to this study  
1.6.1 The RAS/MEK/ERK signaling pathway 
 Mitogen activated protein kinase (MAPK) pathways are responsible for translating 
extracellular signals into cellular responses that regulate cell growth, proliferation, differentiation 
and death (140–142). Pathway activation follows sequential phosphorylation events in a cascade 
comprised of three kinases, MAP3K, MAP2K and MAPK (142,143). MAPK are ser/thr kinases 
that when active phosphorylate both cytoplasmic and nuclear bound targets, such as transcription 
factors to regulate tissue-specific transcription (141–143). With over 200 possible targets, 
structurally supportive proteins known as scaffolds increase the specificity and accuracy of 
MAPK activity (144,145). A scaffold can bind several proteins, keeping them in close proximity 
to control the location and duration of signaling to ensure the rapid propagation of 
phosphorylation (140). 
The most well-studied MAPK pathway is RAS/MEK/ERK (Mitogen-activated protein 
kinase kinase/Extracellular signal related kinase), activated in response to stress and growth 
factor stimulation, where ligands bind to receptor tyrosine kinase (RTKs) to trigger cytoplasmic 
receptor dimerization and auto-phosphorylation (142,146). The SOS (Son of Sevenless) adaptor 
links RTKs to the cascade by activating RAS, a small GTPase, by converting the GDP 
(Guanosine diphosphate) bound to RAS to GTP (Guanosine triphosphate) (146). The 
downstream target of active RAS the MAPK3K RAF will then phosphorylate the dual specificity 
kinase MEK for ERK activation (142). Catalytic ERK can target cytoplasmic, cytoskeletal and 
membrane proteins or enter the nucleus to phosphorylate transcription factors (140). Once the 
signal has been transmitted, GTP is hydrolyzed back to GDP by GAP (GTPase-activating 
protein) for inactivation (Figure 1.6).  
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RAS activation is needed for cell growth, proliferation and survival, and can indirectly 
regulate apoptosis by contributing to the flux between pro-survival and pro-cell death factor 
abundance. The prevailing view is that RAS plays a dual role in apoptosis regulation that is 
context dependent, and can be further complicated by cell type and damage severity. RAS 
activation can promote apoptosis to prevent the onset of cancer, by directly activating the tumour 
suppressors RASSF1 (RAS association domain-containing protein 1) and NORE1 (RASSF5). 
RASSF1 and NORE1 form a complex with MST1 (Macrophage stimulating 1), activator and 
cleavage target of caspase 3, to enhance apoptosis induction (147,148). However, the main role 
for RAS activation is to promote proliferation, apoptosis evasion and survival by 
phosphorylating PI3K for downstream AKT activation (149) (Figure 1.7). In addition, AKT and 
RAF activation by oncogenic RAS can also promote increased MDM2 activation, leading to p53 
degradation and preventing pro-apoptotic gene expression (150).   
1.6.2 The RAS/ERK signaling pathway is conserved in C. elegans  
In C. elegans, downstream of two RTKs, LET-23 and EGL-15, lies the RAS ortholog 
LET-60. The most well-known downstream pathway activated by LET-60 is LIN-45/MEK-
2/MPK-1, which similar to its mammalian counterpart (RAF/MEK/ERK) phosphorylates many 
targets to regulate survival, germline development and cell fate specification (151). Not all 
mutations in genes of this pathway are fatal, however they do cause a host of developmental 
problems. Loss of LET-60 produces vulva-less hermaphrodites (that die when progeny hatch and 
eat their way out of the mother), while LET-60 gain of function mutants possess multiple vulvas 
(152). Reduction in LET-60 signaling can also prevent male tail spicule specification leading to 
failures in mating, as males are unable to properly detect the hermaphrodite vulva for copulation 
and sperm transfer (153,151).  
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LET-60/MPK-1 signaling is also important for germline development and activation of 
both CEP-1 dependent and independent apoptosis. Activation of physiological apoptosis is CEP-
1 independent and removes half of the developing germ cells in the “death loop”. Here, MPK-1 
(ERK ortholog) activation assists the exit of germ cells from pachytene to become fully matured 
oocytes, and mutations in mek-2 (MAP2K ortholog) or mpk-1 can leave worms sterile, as germ 
cells are unable to exit and complete gametogenesis (154). Reduced MPK-1 activation is 
associated with reduced physiological apoptosis and an increase in phosphorylated MPK-1 has 
been found to increase apoptosis, potentially due to an associated reduction in ced-9 transcription 
(38). LIP-1 (MKP3 ortholog) is a MPK-1 phosphatase and thus negative regulator of LET-60 
signaling. In response to IR, similar to LET-60 gain of function mutants, loss of lip-1 allowed for 
unimpeded MPK-1 activation, increased CEP-1 expression and caused a CEP-1 dependent 
increase in germline apoptosis (83).  
1.6.3 The stress activated p38 MAPK pathway is involved in activation of apoptosis 
The SAPK p38 MAPK is activated in response to inflammatory cytokines and various 
forms of stress including oxidative stress, UV and IR to promote cellular health and survival, as 
well as apoptosis (142,143,146,155). Activated p38 MAPK phosphorylates numerous nuclear 
(i.e. p53, MEF2) and cytosolic (i.e. Bax, Tau) targets, and its activity can be regulated through 
scaffold binding (144,156). Dysfunction of p38 MAPK signaling is implicated in various 
pathologies including inflammatory diseases (i.e. arthritis and psoriasis), heart disease, 
neurological disorders and cancer (157).  
There are four p38 MAPK isoforms (α,β,γ,δ), where p38α has been implicated in 
mediating both cell survival and apoptosis by influencing the abundance of pro-apoptotic factors 
(158). Studies in cardiac cells have shown that p38α activation increases apoptosis by increasing 
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BCL2 phosphorylation, and increasing both the expression and translocation of pro-apoptotic 
factor Bax to mitochondria (159,160). p38α can also target and phosphorylate p53 to initiate the 
transcription of pro-apoptotic genes (161). By contrast, a loss of p38α in cardiomyocytes 
increases ERK and AKT activation enhancing cell survival, implying that p38α may also act as a 
negative regulator of these pro-survival pathways (162). In addition, the prolonged activation and 
aberrant p38α function in response to oxidative stress is associated with apoptosis in neurons and 
glial cells, a consequence of neurodegenerative diseases such as Parkinson’s and Alzheimer’s 
(163). However, in non-neuronal cells, in response to oxidative stress induced by hydrogen 
peroxide, p38α activation increased the ATF2 (Activating transcription factor 2) dependent 
transcription of antioxidant gene SOD2 (Superoxide dismutase 2) to prolong cell survival (164).  
1.6.4 The p38 MAPK pathway is conserved in C. elegans  
In C. elegans, the SAPK p38 pathway is conserved and has been identified as a regulator 
of innate immune and oxidative stress responses, and recently has been implicated in germline 
apoptosis. In response to bacterial infection and oxidative stress caused by reactive oxygen 
species (ROS) (i.e. superoxide radicals and hydrogen peroxide) NSY-1 (ASK ortholog) activates 
SEK-1 (MAP2K3/6 ortholog) to phosphorylate the terminal kinase PMK-1 (p38 MAPK 
ortholog). PMK-1 is known to directly target and phosphorylate SKN-1, increasing its 
accumulation within intestinal nuclei to upregulate the transcription of phase II detoxification 
genes (Figure 1.9) (165). Worms treated with the oxidative stress inducer sodium arsenite had 
increased phosphorylated PMK-1 levels, while a loss of either sek-1 or pmk-1 prevented SKN-1 
nuclear accumulation and increased lethality in these mutants (166).  
In response to pathogen infection, such as exposure to Yersina pestis and Pseudomonas 
aeruginosa, worms experience increased PMK-1 activation (167), increased PMK-1 dependent 
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SKN-1 nuclear import, as well as increased expression of SKN-1 target genes gcs-1 (γ-Glutamyl 
Cysteine Synthetase 1 ortholog) and gst-4 (168). PMK-1 has also been found to regulate the 
activity of ATF-7 (ATF2 ortholog), a transcription factor responsible for activation of host 
defense genes such as lysozymes and antimicrobial peptides (169). NSY-1 gain of function 
mutants increased PMK-1 activation and PMK-1 target immune effector gene expression, as well 
as enhanced resistance to P. aeruginosa (170). With these studies, it is thought that as a worm 
ages, they are more easily susceptible to bacterial infection and death due to reduced levels of 
PMK-1 and SKN-1 activity (171).  
 PMK-1 has also been linked to oxidative stress induced germline apoptosis. Following 
exposure to sodium arsenite, levels of apoptosis where found to be higher in cep-1 and egl-1 
mutants. However, under the same conditions germline apoptosis in mpk-1 and pmk-1 mutants 
was lower (172). Reduced PMK-1 activity with pmk-1 RNAi, saw reduced apoptosis levels when 
worms were exposed to Salmonella (173). This suggests that apoptosis caused by pathogen 
exposure is dependent on SAPK signaling and demonstrates that depending on stress type, 
pathways independent of the core apoptotic program are needed to activate apoptosis in the 
germline. The diverse functional role of PMK-1 in immunity, the oxidative stress response and 
apoptosis suggests that the intestine and germline, major worm stress response organs, may 
influence one another to promote cellular protection and health.   
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Figure 1.7: The RAS pathway can activate cell death and promote cell survival  
 
The activation of RAS has been associated with the stimulation of many downstream pathways, 
particularly RAS has been found to promote cell survival by activation of transcription factors 
that lead to cell proliferation and at the same time activate PI3K for the prevention of apoptosis 
through AKT. RAS can also bind to RASSF1 for apoptosis activation to limit proliferation. LG 
indicates a ligand. Adapted and modified from (174).  
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1.6.5 The PI3K/AKT signaling pathway  
AKT is a ser/thr kinase regulated by the PI3K/AKT signaling pathway, responsible for 
the regulation of metabolism, proliferation, cell growth and survival. AKT is phosphorylated in 
response to growth factors, cytokines and stress (175). Ligands bind to the IGF1 (Insulin-like 
growth factor 1) membrane receptor, stimulating the activity of the lipid enzyme PI3K 
(Phosphoinositide 3-kinase) which catalyzes PI(3,4)P2 (PIP2) conversion to PI(3,4,5)P3 (PIP3). 
This recruits and activates PDK1 (Phosphoinositide-dependent kinase 1) and AKT, where a 
conformational change in AKT allows PDK1 to access and phosphorylate Thr308 on AKT (176). 
Once active, AKT localizes to the inner cytosolic space to phosphorylate a variety of substrates 
(175) (Figure 1.8). A primary target of the AKT family (AKT1/2/3) is members of the FOXO 
(Forkhead Box O) transcription factor family, involved in regulating cell cycle arrest and 
apoptosis (177). When AKT phosphorylates FOXO, it is held in the cytoplasm and is unable to 
travel to the nucleus preventing the FOXO dependent transcription of pro-apoptotic BH3 domain 
genes such as Bax (Figure 1.8) (178).  
Activated AKT can also promote cell survival by negatively regulating pro-apoptotic 
factors like Bad, and increase p53 degradation by activating MDM2 (179). However, constitutive 
AKT activation is detrimental and can lead to a cancerous state of increased cell proliferation 
and reduced apoptosis (180). AKT can be attenuated upstream, by the PTEN inhibition of PIP2 
conversion to PIP3. However, AKT can be “turned off” directly in two steps. First, PP2A 
(Protein phosphatase 2A) removes a phosphate group on Thr308 (181), and then AKT 
inactivation is completed when the phosphate group on Ser473 is removed by the phosphatases 
PHLPP1/2 (182). PHLPP phosphatases are vital for the regulation of AKT, since a loss of either 
isoform causes the increased presence of phosphorylated FOXO, MDM2 and p27 (183).  
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1.6.6 The Insulin/Insulin-like growth factor signaling (IIS) pathway in C. elegans 
In nematodes, DAF-16 is the sole FOXO ortholog that controls the transcription of genes 
which regulate lifespan, developmental arrest and participates in the oxidative stress response 
(184,185). The main components of the PI3K/AKT pathway are conserved in C. elegans and is 
commonly referred to as IIS or the DAF-2 pathway. IIS is controlled by the membrane bound 
receptor DAF-2 (IGF1 ortholog). In response to stress, or ligand binding DAF-2 is activated and 
the generation of PIP3 by AGE-1 (PI3K ortholog) causes the translocation of PDK-1 (PDK1 
ortholog), AKT-1 and AKT-2 (AKT1/2 orthologs) to the plasma membrane for phosphorylation 
(186–189). Activated AKT-1/2 then phosphorylate and negatively regulate DAF-16, preventing 
its entry into the nucleus (Figure 1.8) (190).  
For activation, AKT-1 possesses conserved phosphorylation sites at Thr350 and Ser517, 
which are phosphorylated directly by PDK-1 (191). AKT-1 and AKT-2 are negatively regulated 
by DAF-18 (PTEN ortholog) inhibition of PIP3 formation. When the phosphatase PPTR-1 
(subunit of PP2A ortholog) is overexpressed, AKT-1 phosphorylation decreases, while DAF-16 
nuclear localization is increased (192,193). A PHLPP1/2 ortholog exists in C. elegans and is 
known as PHLP-2 (F43C1.1). Although PHLP-2 has predicted enzymatic activity and is found 
expressed in neurons and around the pharynx, it has not yet been shown to directly inhibit either 
AKT isoform (194). When the IIS pathway is “off”, DAF-16 is free to enter intestinal nuclei and 
begin the transcription of genes involved in dauer, phase I detoxification, longevity and 
formation of germline associated nuclear pore complexes (185,195,196).  
The IIS pathway and DAF-16 activation is most well-known for its regulation of worm 
lifespan, oxidative stress and dauer entry. When worms encounter stress in their environment 
such as overcrowding (usually accompanied with starvation), they can divert to an alternate 
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diapause stage known as dauer. Mutations in daf-2 and age-1 extend lifespan significantly, and 
these mutants were also found to be more resistant to stress (197,198). This increased longevity 
and dauer constitutive phenotype was found to be dependent on functional DAF-16, where daf-
16 mutants are unable to developmentally arrest and are thus dauer defective (23).  
How do worms know when to enter dauer? Worms are able to sense changes in their 
environment in the form of pheromones, nutrients and temperature. Their amphid neurons then 
integrate, convert and relay these signals to parallel TGF-β (Transforming Growth Factor Beta) 
and IIS pathways, whose outputs will induce morphological changes including, producing a 
thickened cuticle and buccal plugs, constricting, elongating and slowing worm metabolism, all in 
an effort to enhance their resistance to stress (199,200,23). It is thought that in a healthy, stable 
environment the ample supply of hormones, nutrients and insulin-like peptides (ILPs) enable 
worms to continue with normal reproductive growth and development. There are approximately 
40 predicted ILPs in C. elegans expressed in muscle, neurons and the intestine that can function 
as agonists (i.e. INS-7) or antagonists (i.e. INS-1) of the pathway in response to environmental 
cues and pheromones sensed by the worm (201).  
The IIS pathway is also involved in regulating DNA damage induced germline apoptosis. 
In response to IR, a loss of daf-2 causes a reduction in apoptosis dependent on activated MPK-1, 
yet a loss of daf-16 produced similar levels of apoptosis to the wild type (101). Loss of akt-1 or 
akt-2 increases germline apoptosis but seem to function distinctly, where akt-1 was found to 
negatively regulate CEP-1, while akt-2 was found to inhibit DAF-16 (101,102). In addition, a 
novel ced-3 target substrate CNT-1 (Arf GTPase ortholog), was found to move to the plasma 
membrane after being cleaved by ced-3 to prevent AKT-1 activation (202,203). Interestingly, 
germline apoptosis induced by sodium arsenite increased apoptosis in daf-2, age-1 and akt-1 
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mutants, while apoptosis was reduced with loss of daf-16 function. However, in the same study 
the loss of akt-2 demonstrated reduced apoptosis, which was increased with loss of daf-16 (204). 
This demonstrates that in addition to development and longevity, the IIS pathway contributes to 
the regulation of stress induced germline apoptosis in distinct ways and can be independent of 
CEP-1.  
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Figure 1.8: The C. elegans DAF-2/IIS pathway and its high conservation to the mammalian 
IGF/Insulin signaling pathway 
The mammalian IGF/Insulin pathway is highly conserved in C. elegans, that when activated in 
addition to regulating entry into developmental arrest the DAF-2/IIS pathway is also responsible 
for metabolism and lifespan the regulation. Image adapted from (205).  
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1.6.7 The SKN-1/Nrf2 oxidative stress response pathway  
The accumulation of ROS can lead to DNA damage, mitochondrial dysfunction, protein 
aggregation and contributes to the progression of neurodegenerative diseases such as 
Alzheimer’s and Parkinson’s. Organisms have developed the Nrf2 (Nuclear factor erythroid-
derived 2-like 2) mediated oxidative stress response which eliminates ROS through the 
transcriptional upregulation of antioxidant genes to protect cells against aging and disease (206). 
Nrf2 is a Cap’n’Collar transcription factor activated and stabilized by phosphorylation, allowing 
it to break away from its inhibitor the Cul-Keap1-E3 ligase complex, that normally ubiquitinates 
and labels Nrf2 for degradation (138). Nrf2 then moves into the nucleus to bind to ARE 
(Antioxidant response element) promoter sites to induce the transcription of cytoprotective and 
notable antioxidants genes such as glutathione-synthesizing enzymes (207).  
If highly reactive hydroxyl radicals come into contact with DNA it can destabilize the 
backbone, threatening its integrity. As a result, oxidative stress produced as by-products of 
radiation and other environmental stressors can contribute to tumor progression (208). Increased 
survival and expression of the Nrf2 target gene SOD1 (Superoxide dismutase 1) in human 
glioma cells and mouse hematopoietic myeloid progenitors was observed after exposure to 
radiation (209,210). Nrf2 has also been found to bind to the ARE of 53BP1 (p53-binding protein 
1), a protein involved in NHEJ DNA repair (211). Interestingly, the DNA repair protein BRCA1 
has also been linked to the regulation of the oxidative stress response. BRCA1 has been found to 
physically interact and promote Nrf2 stability, and loss of BRCA1 saw reduced antioxidant gene 
expression and an accumulation of ROS (212). Thus it can be inferred that increased Nrf2 
activity plays a more expansive cytoprotective role to promote cell survival in response to stress 
(213).  
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The C. elegans Nrf2 ortholog is known as SKN-1, and is activated in response to 
oxidative stress, xenobiotics and bacterial infection. SKN-1 is a maternally expressed 
transcription factor that regulates the transcription of similar Nrf2 conserved target genes (214). 
Similar to Nrf2, SKN-1 possesses a conserved DNA binding DIDLID domain at the N-terminus, 
required for transcriptional activation and the ability to interact with its inhibitor WDR-23 
(WD40 repeat protein) (214–216). SKN-1 is required for embryonic fate through maternal 
specification of the endomesoderm, giving rise to cells of body wall muscle and the pharynx, 
making SKN-1 mutations lethal (217). In adult worms, SKN-1 is expressed in amphid 
chemosensory neurons to regulate worm longevity and is highly active in the intestine, the major 
worm oxidative stress response organ (165).  
In response to stress, SKN-1 is regulated positively by MPK-1 and PMK-1 
phosphorylation and enters intestinal nuclei for the transcriptional activation of genes that 
promote longevity, initiates detoxification as well as the unfolded protein response (165). PMK-1 
directly phosphorylates SKN-1 for its nuclear accumulation in response to oxidative stress and 
pathogen infection. Interestingly, a loss of pmk-1 saw no change in lifespan, while RNAi 
knockdown of mpk-1 reduced worm lifespan. Increased MPK-1 signaling with lip-1 RNAi, 
increased lifespan and was found to be dependent on SKN-1. Thus specific MPK-1 
phosphorylation may be the mechanism for SKN-1 dependent regulation of lifespan (165).  
In addition to negative regulation by WDR-23, SKN-1 can also be inhibited through 
phosphorylation by IIS pathway terminal kinases. Inhibition of the IIS pathway with a daf-2 
mutation, increased skn-1 expression levels (218). With a loss of skn-1 function, the extended 
lifespan of long-lived daf-2 mutants is also lost (218). AKT-1, AKT-2 and another IIS target 
kinase SGK-1 (Serum and glucocorticoid inducible kinase 1 ortholog) were found to 
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phosphorylate SKN-1. In the same study, RNAi knockdown of akt-1, akt-2 and sgk-1 all 
increased SKN-1 accumulation into intestinal nuclei (218). Thus IIS terminal kinase activation 
can phosphorylate SKN-1 to inhibit its function, while a reduction of IIS allows SKN-1 nuclear 
translocation for the transcription of phase II detoxification genes, to increase oxidative stress 
resistance and prolong longevity independently of DAF-16 (218).  
EEL-1 is an E3 ubiquitin ligase that can bind to and target SKN-1. A loss of eel-1 early in 
embryogenesis (2-cell stage) reduces the asymmetric expression of SKN-1 (219). Although 
EEL-1 has been found to promote DNA damage germline apoptosis, when examining the 
potential role of SKN-1 in apoptosis, it was found that skn-1 RNAi knockdown produced similar 
levels of germline apoptosis to the wild type in response to IR and thus may not be necessary for 
germ cell death (33). SKN-1 is a maternal determinant, which in the germline is only present as 
an mRNA transcript, while SKN-1 protein is expressed following fertilization (220). In addition 
to regulating development, detoxification and longevity the IIS pathway has been implicated in 
the regulation of DNA damage induced germline apoptosis. In this way, it is possible that like 
Nrf2, SKN-1 may play a greater and more complex role in the regulation of cell survival in C. 
elegans.  
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Figure 1.9: Regulation of SKN-1 by MPK-1/ERK, PMK-1/p38 MAPK and DAF-2/IIS 
pathways 
SKN-1 is regulated by several highly conserved pathways in C. elegans in response to stress. 
Activation of SKN-1 occurs through phosphorylation by the effectors kinases MPK-1 and PMK-
1, while SKN-1 inhibition can occur via activation of the DAF-2/IIS pathway again via 
phosphorylation by AKT1/2 and SGK-1. Adapted and modified from (19).  
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1.7 Rationale, hypotheses and objectives of this study 
Current literature has characterized BRAP2 as an E3 ubiquitin ligase, a cytoplasmic 
retention protein and as an inhibitor of RAS (15,128,131,133). BRAP2 has been found to bind to 
a variety of proteins from diverse signaling pathways, and displays widespread tissue expression, 
most robustly in mammalian testes (133). Its function as a scaffold protein during sperm 
maturation indicates that it may be important for germline development and gametogenesis. 
However, although the role of BRAP2 as a binding protein has been verified in different 
contexts, the biological implications of these interactions have not yet all been interpreted. 
Particularly, the significance of its ability to bind to and prevent BRCA1 nuclear import and 
potentially its function, has not been extensively studied. BRCA1 is an essential tumor 
suppressor that regulates several cellular pathways of the DDR including DNA repair via HR, 
cell cycle arrest and plays a more complex role in apoptosis. 
Previous work from our lab has characterized the conserved BRAP2 ortholog known as 
brap-2 in C. elegans. Koon and Kubiseski (2010) found that the brap-2(ok1492) deletion mutant 
strain experienced L1 developmental arrest and lethality when exposed to the oxidative stress 
inducer paraquat. In addition, brap-2(ok1492) mutants exhibited increased expression of CKI-1 
(p21 ortholog). The L1 stage developmental arrest, lethality and increased CKI-1 expression 
observed in brap-2 mutants were all dependent on functional BRC-1. This revealed that in 
response to oxidative stress, a genetic link exists between BRC-1 and BRAP-2. Our lab also 
discovered that brap-2(ok1492) mutants increased intestinal SKN-1 nuclear accumulation and 
SKN-1 dependent phase II detoxification gene expression, revealing BRAP-2 as a potential 
regulator of SKN-1 and the oxidative stress response (137).  
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The ability of BRAP2 to bind to BRCA1, its involvement in RAS signaling, as well as its 
expression in germline tissue indicate that BRAP2 may be a potential candidate for DDR 
regulation. We have previously determined that BRAP-2 is involved in the regulation of SKN-1 
dependent gene transcription, and identified that a genetic interaction exists between BRAP-2 
and BRC-1 during oxidative stress. Furthermore, we detected a decrease in germ cell death in 
brap-2(ok1492) mutants following exposure to IR and qualitatively, we also observed that brap-
2 mutant animals were morphologically distinct to the wild type. Since BRC-1 function in the C. 
elegans DDR pathway of DNA repair is conserved, and brc-1 mutants’ exhibit increased 
germline apoptosis, we hypothesize that (1) BRAP-2 is a DNA damage response protein, (2) 
BRAP-2 is required to promote DNA damage induced germline apoptosis, and (3) BRAP-2 is 
required for C. elegans development and germline health. The objectives of this research project 
is to identify the biological role of BRAP-2 in the DDR, specifically germline apoptosis, and 
reveal the potential signaling mechanism through which it influences this event, as well as to 
determine the phenotypical consequences a mutation in brap-2 has on worm morphology, 
survival and germline development. 
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2.1 Summary  
As part of the DNA damage response network, the tumour suppressor BRCA1 (Breast 
cancer susceptibility gene 1) is activated to facilitate DNA repair, transcription and cell cycle 
arrest. BRC-1, the C. elegans ortholog of BRCA1, has conserved function in DNA double strand 
break repair, wherein a loss of brc-1 results in high levels of germline apoptosis (1). 
BRAP2/IMP was initially identified as a BRCA1 associated binding protein and previously we 
have shown that the C. elegans brap-2(ok1492) deletion mutant experiences BRC-1 dependent 
larval arrest when exposed to low concentrations of paraquat (2). Since BRC-1 function in the 
germline is conserved, we wanted to determine the role of BRAP-2 in DNA damage induced 
germline apoptosis in C. elegans. We examined levels of germ cell death following DNA 
damage and found that brap-2(ok1492) mutants display reduced levels of germline apoptosis 
when compared to the wild type, and the loss of brap-2 significantly reduced germ cell death in 
brc-1 mutant animals. We also found increased mRNA levels of skn-1 following DNA damage 
in brap-2 mutants, where skn-1 RNAi knockdown in brap-2;brc-1 double mutants, and a loss of 
pmk-1 in brap-2 mutants increased apoptosis. This indicates that brap-2 promotion of cell 
survival requires PMK-1 and SKN-1. Since mammalian BRAP2 has been shown to bind the 
AKT phosphatase PHLPP1, it suggests that BRAP2 could be involved in the PI3K/AKT 
pathway. We found that this interaction is conserved between the C. elegans homologs and that a 
loss of akt-1 in brap-2 mutants increased germline apoptosis. Thus in response to DNA damage, 
our findings suggest that BRAP-2 is required to attenuate the pro-cell survival signals of AKT-1 
and PMK-1/SKN-1 to promote DNA damage induced germline apoptosis.  
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2.2 Introduction 
Apoptosis is an essential process in development and as part of the DNA damage 
response ensures the elimination of abnormal cells that can lead to tumor formation and the onset 
of cancer (3).  In C. elegans, apoptosis is genetically conserved and functions in the germline to 
provide cytoplasmic components and maternal determinants to growing oocytes, as well as 
remove cells whose DNA has been damaged beyond repair by exogenous stressors such as 
ionizing radiation (IR), chemicals and toxins (4).  
 Apoptosis activated by the p53-like protein CEP-1 occurs in the pachytene region of the 
germline, known as the “death loop” (4). DNA damage leads to the activation of upstream DNA 
damage sensors that phosphorylate and activate CEP-1 (5–7). CEP-1 transcriptional upregulation 
of pro-apoptotic factors EGL-1 and CED-13 release CED-9 inhibition of CED-4 to activate 
CED-3 for the execution of apoptosis (6). BRC-1 (BRCA1 ortholog) has been reported to 
facilitate the conserved repair of DNA double strand breaks through homologous recombination 
through inter-sister recombination (1). brc-1 mutants exhibit increased levels of germline 
apoptosis, increased embryonic lethality and X-chromosome non-disjunction leading to an 
increase in males (8).  
 BRAP2 (BRCA1-binding protein 2 or BRAP as listed in the HUGO database) in 
mammalian systems has been characterized as a RAS-responsive effector protein, an E3 
ubiquitin ligase and a cytoplasmic retention protein (9). BRAP2 was first found to bind to the 
nuclear localization signal (NLS) motifs of BRCA1 and retain BRCA1 in the cytoplasm, 
preventing its nuclear localization (10). BRAP2 has also been found to bind and prevent the 
nuclear import of other proteins such as SV40 T antigen, p21 and CDC14 (13–15). Recently, 
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BRAP2 has been found to bind to and act as a scaffold protein for PHLPP1, an AKT protein 
phosphatase, in mouse testes (11). The AKT pathway is also conserved in C. elegans and is 
known as the DAF-2 or Insulin/Insulin-like growth factor signaling (IIS) pathway, which 
regulates the oxidative stress response, longevity and developmental arrest (12,13).   
In C. elegans, BRAP2 is conserved and is known as BRAP-2 (2). When exposed to 
oxidative stress induced by paraquat, brap-2 mutants experience lethality and L1 developmental 
arrest due to high levels of CKI-1 (p21 ortholog) in seam cells (2). It was determined that a loss 
of BRC-1 in brap-2 mutants prevented lethality and developmental arrest, as well as decreased 
CKI-1 levels, establishing a genetic link between BRAP-2 and BRC-1 in this context. In 
response to oxidative stress, the transcription factor SKN-1 (Nrf2 ortholog) is activated to initiate 
detoxification (14). Previously, we also found that a loss of brap-2 increases SKN-1 target gene 
expression (15).  
 Due to the conservation of BRC-1 function in C. elegans and the genetic interaction 
between BRC-1 and BRAP-2 upon oxidative stress, we examined the role of BRAP-2 in DNA 
damage induced germline apoptosis. We found that brap-2(ok1492) mutants’ exhibit a reduction 
in DNA damage induced germline apoptosis and that germline apoptosis induced by loss of 
BRC-1 requires BRAP-2. We also determined that brap-2 mutants are dauer defective and the 
interaction between PHLP-2 (C. elegans homolog of AKT protein phosphatase PHLPP1/2) and 
BRAP-2 is conserved in C. elegans. We also found that a loss of PMK-1, SKN-1 and AKT-1 in 
brap-2 mutants increased germline apoptosis, while phlp-2 mutants have reduced apoptosis.  
Taken together, these observations suggest a model in which a loss of BRAP-2 limits DNA 
damage induced germline apoptosis and promotes cell survival through the regulation of the 
PMK-1 activated SKN-1/Nrf2 oxidative stress response pathway and the IIS Pathway.  
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2.3 Materials & Methods 
2.3.1 C. elegans strains and genetics  
All worm strains were cultured under standard conditions, as previously described (16). Strains 
were obtained from the Caenorhabditis Genetics Center located at the University of Minnesota 
and from the National Bioresource Project in Tokyo, Japan. Double mutant strains were 
generated according to standard protocols. The N2 Bristol strain was used as the wild type, and 
unless noted otherwise all experiments were conducted at 20°C. The following strains were used 
in this study: akt-1(ok252)V (YF198), akt-2(ok393) X (VC204), brap-2(ok1492) II (YF15), brap-
2(ok1492) II; akt-1 (ok525) V (YF198), akt-1(ok252) V;phlp-2 (tm7788) III (YF193), brap-
2(ok1492) II; akt-2(ok393) X (YF188), brap-2(ok1492)/mIn 1 [MIs14dyp10 (e128)] II denoted 
as brap-2(ok1492)/+ (YF104), brc-1(tm1145) III (DW102), brap-2(ok1492) II; brc-1(tm1145) 
III (YF64), cep-1(gk138) I (YF62), brap-2(ok1492) II;cep-1(gk138) I (YF63), bcIs39 [lim-
7p::ced-1::GFP + lin-15(+)] (MD701), bcIs39; brap-2(ok1492) II (YF180), ced-9(n2812) III/hT2 
[bli-4(e937) let-?(q782) qIs48] (I;III); nIs106 X (PD9927), brap-2(ok1492) II; ced-9(n2812) 
III/hT2 [bli-4(e937) let-?(q782) qIs48] (I;III); nIs106 X (YF179), daf-16(mu86) I (CF1038), 
brap-2(ok1492) II;daf-16(mu86) I (YF19), brc-1(tm1145) III; daf-16(mu86) I (YF189), mpk-
1(ga111) unc-79(e1068) III (temperature sensitive, maintained at 15ºC) (SD939), brap-
2(ok1492) II; mpk-1(ga111) unc-79(e1068) III (YF94), pmk-1(km25) IV (KU25), brap-
2(ok1492) II; pmk-1 IV (YF197), phlp-2 (tm7788) III (YF200), daf-16(mu86) I; muIs61 
(CF1139), brap-2(ok1492) II; daf-16(mu86) I; muIs61 (YF190).  
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2.3.2 Worm Synchronization 
For all worm assays, worms were synchronized via egg lay as described by the Morimoto Lab 
(http://groups.molbiosci.northwestern.edu/morimoto/research/Protocols). 
2.3.3 Irradiation 
Worms were synchronized to the L4 stage and exposed to ionizing radiation using a 137Cs 
sources (in coordination with the Derry Lab, McMaster Building & Sick Kids Peter Gilgan 
Research Tower) at indicated doses. Worms were left to recover for 18-24 hours on Nematode 
Growth Media (NGM) plates before visualization, apoptosis, RNA extraction and qRT-PCR, and 
mitotic arrest analyses. 
2.3.4 Fluorescence Microscopy 
Worms were picked and anesthetized using 2 mM Levamisole (Sigma L9756) and mounted on 
2% agarose pads. Images of fluorescent worms were taken using a Zeiss LSM 700 confocal 
laser-scanning microscope with Zen 2010 Software. 
2.3.5 Germline Apoptosis Assay 
Worms were allowed to recover for 18-24 hours and corpses (apoptotic cells) were scored using 
Acridine Orange (AO) staining as previously described (17,18). Worms were paralyzed in 2 mM 
Levamisole and mounted on 2% agarose pads, where 15-20 gonad arms per genotype were 
scored per treatment. Apoptotic cells in developing embryos were scored in specific embryonic 
stages directly using the ced-1p::GFP strain.  
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2.3.6 DNA Staining  
To quantify germline nuclei, whole worms were stained with DAPI as previously described (19). 
Z-stack images were taken and using the Zen 2010 Lite software free-form surface area 
measurement tool was used to measure gonad surface area of one representative slice. The 
ImageJ Cell Counter plugin was used to determine the total number of nuclei per zone in one 
gonad arm per worm in one representative slice.  
2.3.7 Gonad Dissection  
Gonad dissection and immunostaining was performed as previously described (20), with the 
following changes: Approximately 20-30 synchronized 1 day old adults were mounted onto 20 
µL of 2 mM Levamisole in M9 buffer on Superfrost Polylysine (Fisher 12-5550-15) coated 
slides in an area made with Immaedge Hydrophobic Pen (VECTOR Labs H-4000) and the heads 
or tails were removed with a “scissor-like” motion using 27G syringe needles. To this, 10 µL 2% 
paraformaldehyde was added, coverslip mounted and were allowed to sit for 10 minutes and then 
frozen on an aluminum block on dry ice for 10 minutes. Slides were then freeze cracked using a 
razor blade and submerged in -20°C methanol for fixation for 1 minute.  
2.3.8 Immunostaining 
Dissected Germlines: Following methanol fixation, slides were washed with 1X PBST 3 times 
for 5 minutes. Incubated for 1 hour in 2% BSA for 1 hour in a humid chamber. Primary antibody 
was added and incubated overnight at room temperature. Slides were washed 3X with 1X PBST 
and then secondary antibody was added dropwise and incubated for 1 hour at room temperature 
in a humid chamber in the dark. Slides were washed 4X with 1X PBST for 5 minutes and in the 
third wash, 1 µg/mL DAPI (Sigma D9542) was added. Before mounting, 3 µL of Prolong Gold 
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Anti-Fade Reagent (ThermoFisher P36930) was added and coverslips were sealed using clear 
nail polish. Antibodies used were: rabbit anti-BRAP-2 (1:100) and Alexa Fluor 488 (1:1000) 
(ThermoFisher A11001) secondary antibody was used for fluorescent visualization. Rabbit 
polyclonal anti-sera against C. elegans BRAP-2 (EEED8.16) was generated by the Toronto 
Recombinant Antibody Centre of the University of Toronto using a GST fusion protein with 
BRAP-2 antigen corresponding to residues 108 to 134 which lie in the N terminus of the protein.  
Worm Western Blot: Approximately 200 µL of packed mixed-stage worms were washed 3X 
with M9 buffer and then re-suspended in worm lysis buffer [50 mM HEPES pH 7.5, 100 mM 
NaCl, 10% Glycerol, 1 mM EDTA, protease (EMD Millipore 539137) and phosphatase inhibitor 
cocktail II (Sigma P5726) and III (Sigma P0044)] followed by sonication (10s ON/10s OFF, 
10% amplitude for 1.5 min). The lysates were cleared twice by centrifugation (15 minute at 13, 
000 x g) and the total protein lysate concentration was measured using the BCA assay according 
to the manufacturer’s protocol (ThermoScientific 23227). Proteins (50 µg of protein per 
genotype) were resolved using 10% SDS-PAGE gels and transferred to Millipore Immobilon-P 
PVDF (IPVH0010) membranes. Membranes were blocked with 5% skim milk and then probed 
with the following antibodies: anti-phospho p38 MAPK (Cell Signal 9211S), anti-AKT-1 527 
(1:1000), anti-AKT-1 128 (1:1000) (Gift from the Derry Lab), and anti-tubulin (1:2000) (Cell 
Signal 3873). For visualization, proteins were detected using Luminata Crescendo Western HRP 
Substrate (EMD Millipore WBLURO100) and blots were imaged using the DNR Bio Imaging 
Systems Microchemi System. Band density was measured and normalized to their respective 
anti-tubulin protein levels using the Gel Analyzer in ImageJ.  
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2.3.9 RNA Interference (RNAi) Analysis  
Worms were synchronized on RNAi plates (NGM containing 0.4 mM IPTG, 100 µg/mL 
Ampicillin and 12.5 µg/mL Tetracycline) and fed with E. coli HT115 (DE3), transcribing double 
stranded RNA (dsRNA) from fusion bacterial plasmids homologous to the target with pL4440 
used the control. When animals reached the 1st day of adulthood they were then treated and 
assayed for germline corpse quantification. The skn-1 RNAi plasmid was obtained from a 
transcription factor specific RNAi library, as described (41). The akt-1 RNAi plasmid was 
purchased from GE Dharmacon (CeRNAi Feeder C12D8.10 10014-B-6). The brap-2 RNAi 
construct was made by amplifying region 1-843 nucleotides of the brap-2 ORF by PCR, using 
the EST yk1134a01 as template, and cloning into the KpnI site of pL4440. The phlp-2 RNAi 
construct was made by amplifying region 2618-2800 nucleotides of the predicted phlp-2 ORF 
(F43C1.1; Wormbase Version WS258) by PCR, using the EST yk1149d03 as template, and 
cloning into the KpnI site of pL4440. 
2.3.10 RNA Isolation and Quantitative Real Time PCR (qRT-PCR) 
Worm RNA Isolation, qRT-PCR and data analysis was performed as described previously (15). 
Approximately 100 µL of packed mixed-stage worms (IR treated and untreated controls) were 
collected and washed with M9 buffer 3X and unless extraction occurred immediately, samples 
were frozen at -80ºC. RNA was extracted with TRI Reagent (Sigma 93289) as follows: Pelleted 
RNA was recovered with RNase-free water and residual DNA was digested using the DNA-Free 
Kit (Ambion AM1906). Total RNA concentration was measured using NanoDrop2000 and 0.5 
µg of RNA was used to prepare cDNA following the manufacturer’s protocol using the RNA to 
cDNA kit (Applied Biosystem 4387406). To quantify mRNA levels, qRT-PCR was performed 
53 
 
using SYBR green premix (Clontech 693676)/SensiFast SYBR Green (FroggaBio BIO-98005) 
and the Qiagen Rotor-Gene Q System (Qiagen R0511133). Data were derived from 3 biological 
replicates. Data analysis was performed using the Applied Biosystems Comparative CT Method 
(ΔΔCT Method). mRNA expression levels of each strain was compared relative to the wild type 
(N2) control, where the housekeeping gene act-1 (Actin) was used as the endogenous control for 
normalization. To verify equal primer amplification efficiency a standard curve for each set of 
primers was constructed using a serial dilution of cDNA. Using the qPCR Efficiency Calculator 
(ThermoFisher), amplification efficiency (%) of the qPCR reaction was determined based on the 
R2 value and the slope of the standard curve.  
2.3.11 DAF-16 Localization Assay 
DAF-16 expression was viewed in vivo using the reporter strain CF1139. To investigate DAF-16 
expression in a brap-2(ok1492) mutant background, transgenic strains were generated using 
standard protocols and confirmed by Single Worm PCR (SW-PCR). Worms were synchronized 
to L4 stage and treated with 5 mM sodium arsenite (Sigma 35000-1L-R) in M9 Buffer for 1.5 
hours to induce acute stress (21). For each genotype, worms were visualized and DAF-16::GFP 
expression was scored as cytoplasmic, intermediate or nuclear (22).  
2.3.12 Dauer Defective Assay  
The dauer defective assay was performed as previously described (23). Single adult worms from 
each strain were picked onto individual OP50 seeded NGM plates and allowed to grow for 2 
weeks to enter dauer developmental arrest. Each plate was flooded with 1 mL of 1% SDS 
solution and allowed to sit for 30 minutes. Each plate was then observed under a 
stereomicroscope to assess the state of the worms. If worms were found to be thrashing on the 
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plate they were confirmed to have survived (proper entry into dauer). If worms were found to be 
motionless they were deemed dead (failed to enter dauer). For each genotype, a minimum of 40 
starved plates were examined  
2.3.13 Survival Analysis  
Synchronized worms were raised at 20°C. Worms were exposed to 60 Gy IR at the L4 stage and 
survival was scored beginning on the first day of adulthood and compared to non-irradiated 
controls. Worm survival was scored every 2 days, with worms pronounced dead if no response to 
prodding at the head or tail was produced. Missing worms or those that developed “bag of 
worms” phenotype, were censored from the analysis. Worms were transferred to fresh NGM 
plates every 2 days.  
2.3.14 Plasmid Construction  
To construct 3xFLAG::PHLP-2, the C-terminal region of PHLP-2 (1428bp) was amplified from 
worm cDNA and the product was cloned in frame to a BamHI and EcoRI digested pCMV 7.1 
(3xFLAG) vector. The N-terminal region (1682bp) of PHLP-2 was amplified from synthesized 
DNA (Biomatik) using the Wormbase F34C1.1 sequence into a NotI and BglI digested pCMV 
7.1 (3xFLAG) vector containing the PHLP-2 C-terminal region, using the HI-FI Assembly Mix 
(NEB M5520A) following the manufacturer’s protocol.  
2.3.15 GST Pull Down Assay and Western Blot Analysis  
In this study, Human Embryonic Kidney (HEK) cells were used to assess physical interactions 
between our C. elegans proteins of interest. HEK cells were cultured in Dulbecco’s Modified 
Eagle’s Medium supplemented with 10% Fetal Bovine Serum. Cells were co-transfected for 48 
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hours, with 5 µg DNA of each mammalian expressing construct using polyethylenimine (PEI) 
(Sigma 408727-100 mL) and Optimem (Clontech 31985). The interaction between GST::BRAP-
2 and 3xFLAG::PHLP-2, and GST::ΔCT-BRAP-2 and 3xFLAG::PHLP-2, was verified through 
co-transfection in HEK-293T cells and a GST pull-down assay. Cells were lysed in lysis buffer 
(1X TBS, 1% NP-40, 1% Glycerol, 150 mM NaCl, and complete protease inhibitor cocktail). 
The GST tagged protein was then pulled down from cell lysates using Glutathione Sepharose 
Beads (GE Healthcare 45000139), according to the manufacturer’s protocol with a modification, 
washing of the beads was carried out 6X for 15 minutes before sample analysis. Samples were 
analyzed by standard SDS polyacrylamide gel, followed by Western Blot. The following 
antibodies were used: anti-FLAG M2 (1:5000) (Sigma F1804), anti-GST (1:5000) (Cell Signal 
2625P). Proteins were then detected using SuperSignal West Femto Maximum Sensitivity 
Substrate (ThermoScientific 34095) and blots were imaged using the DNR Bio Imaging Systems 
Microchemi System.   
2.3.16 Statistical Analysis 
Statistical analysis was performed with GraphPad Prism 5 Software. Statistical significance was 
determined using Two-way ANOVA and Bonferroni post tests for comparison between different 
groups. Student’s t-test was performed when comparing two means. P values of <0.05 were 
taken to indicate statistical significance. Error bars represent +/- standard error of the mean.  
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2.4 Results  
 
2.4.1 BRAP-2 promotes DNA damage induced germline apoptosis 
Since BRC-1 function in the DNA damage response is conserved in the germline, we 
used an anti-BRAP-2 antibody and immunostained wild type dissected germlines to identify the 
expression pattern of BRAP-2. We found BRAP-2 to be expressed in the cytoplasm of both wild 
type and brap-2(ok1492) mutant hermaphrodite germlines, surrounding germline nuclei creating 
a “honeycomb” effect, prior to and following exposure to DNA damage (Figure S2.1). 
Localization of BRAP-2 in the germline suggests that it may be necessary for proper germline 
development and may also function to regulate other DNA damage response events including 
apoptosis, mitotic arrest and DNA repair.  
This study focused on the brap-2(ok1492) mutant, which possesses a 1540 bp deletion in 
the C-terminal region (removing exons 5-8, ZnF-UBP and leucine heptad repeats domains) 
(Figure S2.2) (2).  First, to determine whether BRAP-2 is necessary for the induction of germline 
apoptosis we scored the number of apoptotic cells (corpses) in brap-2 mutants. Unlike brc-1 
mutants, we observed a decrease in apoptosis in brap-2(ok1492) mutants compared to the wild 
type following DNA damage (Figure 2.1A). When we introduced the ced-1p::GFP reporter strain 
in brap-2(ok1492), allowing for both early and late phase apoptotic cells to be detected (18), a 
50% reduction in corpse appearance following DNA damage was observed (Figure S2.3). 
However, physiological levels of apoptosis in brap-2(ok1492) mutants are similar to the wild 
type (Figure 2.1A), indicating that brap-2 may specifically regulate DNA damage induced 
germline apoptosis.  
Since we previously established a genetic link between BRC-1 and BRAP-2 during 
oxidative stress and observed that BRAP-2 may promote DNA damage induced germline 
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apoptosis, we hypothesized that brap-2 is required for the high levels of germline apoptosis in 
brc-1 mutants. To test this, we generated a brap-2(ok1492);brc-1(tm1145) double mutant and 
scored apoptosis levels following IR. At 60 Gy, we observed a significant reduction in germ cell 
death at both 60 and 120 Gy (Figure 2.1A). When both wild type and brc-1(tm1145) mutants 
were fed brap-2 RNAi, a similar 2.5-fold reduction in apoptosis was observed (Figure 2.2A). 
This indicates that excessive apoptosis caused by a loss of brc-1 is dependent on brap-2. 
Following DNA damage, heterozygous brap-2(ok1492) mutants [brap-2(ok1492)/+], which 
contain one wild type allele and one mutant allele (ok1492) for brap-2, display similar levels of 
apoptosis to the wild type (Figure 2.2B). This suggests that in this context, one wild type brap-2 
allele is able to restore apoptosis. Thus reduced cell death caused by brap-2(ok1492) may be a 
homozygous recessive trait. Even 48 hours after DNA damage exposure, brap-2(ok1492) 
mutants displayed low levels of apoptosis compared to the wild type (Figure 2.3). Therefore 
brap-2 does not affect the timing or kinetics of corpse appearance.  
To ensure that reduced apoptosis in brap-2 mutants was not caused by a decrease in germ 
cell number, we scored the number of nuclei before and after DNA damage using whole worm 
DAPI staining (19). The number of germline nuclei per µm2 in brap-2(ok1492) mutants at 0 and 
60 Gy did not differ significantly compared to the wild type (Figure 2.4A). Although 
physiologically, we found brap-2 mutants experienced a 20% reduction in total germline nuclei 
compared to the wild type (Figure 2.4B), we believe that this does account for the consistent and 
greater than 50% reduction in apoptosis seen in brap-2 mutants following DNA damage. In order 
to determine whether BRAP-2 is involved in the regulation of apoptosis of somatic cells, we 
scored the number of apoptotic cells in developing embryos using a ced-1p::GFP reporter strain. 
58 
 
We found that in 5 distinct stages of embryonic development, brap-2(ok1492) mutants displayed 
no significant difference in the number of corpses when compared to the wild type (Figure 2.4C).  
 The 9-1-1 checkpoint (MRT-2, HUS-1, CLK-2) is a complex of protein sensors that 
interpret DNA damage signals and relay them to induce mitotic arrest in an attempt to repair 
DNA (8). If the damage is beyond repair, signals are sent to ATM-1 and ATL-1 kinases that can 
activate CEP-1 (p53 ortholog) for the induction of apoptosis (5,25). In the C. elegans germline, 
nuclei that have arrested in the mitotic zone can be viewed directly, enlarging transiently 
following DNA damage to enter G2 phase cell cycle arrest (19). Interestingly, brap-2(ok1492) 
mutants displayed an increase in mitotically arrested nuclei physiologically, and a more robust 
proportion of arrested nuclei following IR exposure (Figure 2.5). This suggests that while a loss 
of BRAP-2 may potentially enhance mitotic cell cycle arrest, BRAP-2 is not required for mitotic 
arrest induction and thus does not function as a DNA damage sensor upstream of CEP-1. 
Therefore, a loss of BRAP-2 does not (i) alter the timing of corpse appearance, (ii) inhibit 
germline proliferation, (iii) or prevent mitotic arrest. These results suggest that BRAP-2 
specifically promotes DNA damaged induced germline apoptosis and is required for a brc-1 
mutant triggered activation of apoptosis. 
Interestingly, when exposed to stressors such as paraquat and IR, DNA repair mutants 
like brc-1 live longer than the wild type (26). We found that before and after DNA damage 
exposure, mean survival of brap-2 mutant animals is reduced, living on average 2 days less than 
the wild type. However, with the loss of brc-1 the mean survival of brap-2(ok1492) mutants was 
extended to resemble the wild type, both before and after DNA damage. Therefore, this suggests 
that reduced survival caused by a loss of brap-2 is dependent on BRC-1 (Figure S2.4). 
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Figure 2.1: BRAP-2 promotes DNA damage induced germline apoptosis  
(A) Following IR brap-2(ok1492) mutants displayed a significant reduction in apoptosis 
compared to the wild type (N2). At 60 Gy, brc-1(tm1145) mutants have an incidence of 9.20 ± 
0.90 corpses, while brap-2;brc-1 double mutants exhibit a 4.5-fold decrease in apoptosis with 
2.02 ± 0.17 corpses. A reduction in apoptosis with a loss of brap-2 is also observed at 120 Gy. 
(B) Representative images of germline corpses (indicated with yellow arrows) 24 hours post IR. 
A significant reduction of apoptosis was observed in brap-2 and brap-2;brc-1 double mutants 
compared to N2 and brc-1 mutants. Results represent 3 independent trials. Two trials were 
completed at 120 Gy. Corpses were scored 24 hours post IR using Acridine Orange (AO). 
p<0.001***.  
0 Gy 60 Gy 120 Gy
0
2
4
6
8
10
12
14
16
18
20
N2
brc-1(tm1145)
brap-2(ok1492)
brap-2(ok1492);brc-1(tm1145)
***
***
***
ns
***
***
c
o
rp
s
e
s
/ 
g
o
n
a
d
  
a
rm
60 
 
A 
     
 
 
B 
 
      
 
 
 
Figure 2.2: One wild type brap-2 allele restored apoptosis following DNA damage 
 
(A) Using brap-2 RNAi to knockdown brap-2 expression, a 2.5-fold reduction in apoptosis was 
observed in wildtype (N2) and brc-1 mutant animals. Worms were grown on brap-2 RNAi 
bacteria or control pL4440, irradiated at the L4 stage and corpses were scored 24 hours post IR 
using AO. (B) Heterozygous brap-2 [brap-2(ok1492)/+] worms displayed similar levels of 
apoptosis to N2, indicating that one wild type brap-2 allele restores apoptosis to wild type levels. 
Corpses were scored 24 hours post IR using AO. Results represent 3 independent trials. 
p<0.001***, p<0.01**. 
 
 
 
 
0 Gy 60 Gy
0
2
4
6
8
10
12
N2 pL4440
N2; brap-2 RNAi
brc-1(tm1145) pL4440
brc-1(tm1145); brap-2 RNAi
**
***
***
c
o
rp
s
e
s
/ 
g
o
n
a
d
  
a
rm
0 Gy 60 Gy
0
2
4
6
8
10
N2
brap-2(ok1492)/+
ns
ns
c
o
rp
s
e
s
/ 
g
o
n
a
d
  
a
rm
61 
 
A 
       
B 
 
 
 
 
Figure 2.3: BRAP-2 does not alter the rate of corpse appearance 
(A) Reduced apoptosis in brap-2(ok1492) mutants was maintained 48 hours after IR exposure. 
This indicates that a loss of BRAP-2 does not delay corpse appearance. (B) Representative 
confocal images taken of germlines 48 hours post 60 Gy of IR. Worms were stained with AO 
and corpses were scored after 48 hours, following 0 and 60 Gy. Results represent 3 independent 
trials. Yellow arrows indicate apoptotic cells. Two independent trials at 60 Gy were completed 
for cep-1(gk138). p<0.001***, p<0.01**, p<0.05*. 
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Figure caption on next page.  
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Figure 2.4: BRAP-2 does not affect germ cell proliferation and is specific to germline 
apoptosis  
 
(A) The number of germline nuclei per µm2 at 0 and 60 Gy in these mutants did not differ 
significantly from each other and were similar to the wild type (N2). Thus a mutation in brap-2 
does not alter germ cell number. Results represent N = 40 per genotype. (B) Total germline 
nuclei at 0 and 60 Gy were counted in these mutants. An approximately 20% reduction is seen in 
brap-2 mutants compared to the wild type at 0 Gy, but no difference is observed at 60 Gy. 
Results represent N =14-31 per genotype. One day old whole worms were fixed and stained with 
DAPI. The surface area was measured using Zen 2010 Lite Software and the total number 
germline nuclei were scored in 1 slice of each Z-stack using ImageJ. (C) The number of corpses 
detected in each embryonic stage in brap-2(ok1492) mutants is similar to the wild type. This 
suggests that BRAP-2 is specific to germline cell death regulation and is not involved in somatic 
or developmental programmed cell death. Z-stack images were taken and corpses were counted 
manually in each embryonic stage using a ced-1p::GFP reporter strain. Results represent N = 8-
12, per embryonic stage per genotype. p<0.001***, p<0.01**.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
 
A 
        
 
B 
 
 
Figure 2.5: brap-2(ok1492) induces robust mitotic arrest following DNA damage 
(A) brap-2(ok1492) mutants displayed an increase in the number of arrested nuclei (per µm2) in 
the mitotic zone (MZ) compared to the wild type (N2). (B) Representative confocal images of 
the MZ for each genotype at 0 and 60 Gy. One day old whole worms were stained with DAPI. 
Arrested nuclei transiently enlarge (indicated by white arrows) and were scored manually using 
Zen 2010 Software. White asterisk indicates distal tip of the gonad. Results represent N= 15-40 
per genotype. p<0.001***, p<0.01**, p<0.05*. 
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2.4.2 BRAP-2 functions upstream or independently of the CEP-1 activated programmed 
cell death pathway 
DNA damage induced germline apoptosis is activated by a conserved canonical signaling 
pathway initiated by CEP-1, the C. elegans p53-like protein that activates cell death through the 
transcriptional up-regulation of egl-1 and ced-13 (BH3 orthologs) (27–29). EGL-1 and CED-13 
proteins bind to and inhibit CED-9 (BCL2 ortholog), an anti-apoptotic protein that normally 
impedes apoptosis by inhibiting CED-4 (APAF1 ortholog) from activating the downstream 
caspase CED-3 (28–30). To determine whether a loss of brap-2 affects the expression of egl-1 
and ced-13, we performed qRT-PCR before and after DNA damage exposure. brap-2 mutants 
displayed a significant increase in both egl-1 and ced-13 mRNA expression levels both prior to 
and following DNA damage induction (Figure 2.6A,B). This increased expression of egl-1 and 
ced-13 indicates that brap-2(ok1492) mutants may have increased CEP-1 activity, where BRAP-
2 may act as a potential negative regulator of CEP-1.  
Following DNA damage, cep-1 mutants display a resistance to apoptosis, which is 
associated with the failure to activate the transcription of egl-1 and ced-13 (Figure 2.7) (31). 
brap-2(ok1492) mutants display reduced apoptosis similar to cep-1 mutants following DNA 
damage exposure (Figure 2.7A). We also found that increased egl-1 and ced-13 expression levels 
in brap-2 mutants is abolished with a loss of cep-1 (Figure 2.7B). Thus egl-1 and ced-13 
expression in brap-2 mutants is dependent on CEP-1. CED-9 (BCL2 ortholog) is a “pro-
survival” gene that prevents apoptosis, and its ablation leads to immense germ cell death and 
inviability (32). Interestingly, brap-2 mutants also displayed elevated ced-9 mRNA levels 
following DNA damage (Figure 2.6C). To investigate the potential interaction between BRAP-2 
and CED-9, we generated brap-2;ced-9 double mutants and assessed apoptosis levels. We 
observed that a loss of brap-2 in ced-9 mutants failed to reduce the high levels of apoptosis seen 
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in ced-9 mutants (Figure 2.8), indicating that the decreased apoptosis seen in brap-2 mutants 
probably requires CED-9. Together, this suggests that BRAP-2 may function upstream or 
independently of the CEP-1 activated pathway of DNA damage induced germline apoptosis.  
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Figure caption on next page.  
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Figure 2.6: brap-2(ok1492) increased apoptosis gene expression 
 
Using qRT-PCR, mRNA levels of (A) egl-1, (B) ced-13 (pro-apoptotic) and (C) ced-9 (anti-
apoptotic) were quantified at 0 Gy and following 60 Gy of DNA damage. Following IR, levels of 
egl-1, ced-13 and ced-9 are enhanced in brap-2(ok1492) mutants. Results represent 3 
independent trials, normalized to act-1 of the wild type (N2) 0 Gy. p<0.001***, p<0.01**, 
p<0.05*. 
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Figure caption on next page.  
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Figure 2.7: Expression of egl-1 and ced-13 in brap-2 mutants is dependent on CEP-1 
(A) Levels of apoptosis in brap-2(ok1492) mutants is similar to that of cep-1(gk138) mutants. 
Results represent 3 independent trials. Corpses were scored and visualized 24 hours post IR 
using AO. (B) brap-2(ok1492) displayed increased egl-1 and (C) ced-13 expression levels that 
were reduced with the loss of cep-1. This indicates that the potential increased CEP-1 activity in 
brap-2 mutants is dependent on CEP-1. Transcript levels were quantified using qRT-PCR prior 
to and following DNA damage. Results represent 3 independent trials, normalized to act-1 of the 
wild type (N2) at 0 Gy. p<0.001***, p<0.01**, p<0.05*. 
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Figure 2.8: Loss of brap-2 did not reduce apoptosis in ced-9 mutants  
 
(A) Loss of CED-9 causes massive germline cell death and inviability. A loss of brap-2 in ced-9 
mutants produced no significant difference in apoptosis prior to or following DNA damage.     
(B) Representative images of irradiated mutant gonads for comparison 24 hours post IR. Worms 
were irradiated at the L4 stage and corpses were scored using AO 24 hours post IR. Yellow 
arrows indicate apoptotic cells. Results represent N= 31-41 and N= 11-12 gonads at 0 Gy and 60 
Gy, respectively.  
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2.4.3 Loss of SKN-1/Nrf2 increases apoptosis in brap-2;brc-1 mutants  
SKN-1 is an essential transcription factor for the initiation of gene expression to protect 
against harmful reactive oxygen species (ROS), and serves as an embryonic precursor for 
intestinal and mesoendodermal development (14,33). Overexpression of SKN-1 leads to 
extension of the C. elegans lifespan that may be attributed to ROS removal maintaining cellular 
homeostasis, helping to promote health and survival (34,35). IR can directly harm cells by 
inducing double-strand breaks (DSBs) in DNA and indirectly, through ‘radiolysis’, the 
hydrolysis of water molecules leading to ROS production and possible disruption of nucleic 
acids, proteins and lipids (50).   
Previously, we have found that a loss of brap-2 increased skn-1 mRNA levels, and 
increased SKN-1 intestinal nuclear localization and phase II detoxification gene expression (15). 
This prompted us to determine whether SKN-1 is involved in the regulation of DNA damage 
induced germline apoptosis. We found that brap-2 mutants experience a 2-fold increase in skn-1 
mRNA levels after IR (Figure 2.9A). Thus we hypothesized that SKN-1 acts as a transcriptional 
regulator of apoptosis. To determine if core apoptosis gene expression requires SKN-1, we fed 
wild type worms with skn-1 RNAi and measured cep-1, egl-1, ced-13 and ced-9 mRNA levels. 
skn-1 RNAi produced significant reductions in all genes tested (Figure 2.9B), indicating that at 
least at physiologically, SKN-1 may be required for apoptosis gene expression.  
We then asked whether the reduction of apoptosis in brap-2 mutants was dependent on 
SKN-1. Using RNAi, we knocked down skn-1 in brap-2 mutants and scored germline apoptosis 
before and after IR. As previously reported, we also observed that skn-1 RNAi knockdown does 
not affect apoptosis levels in wild type worms (31). Although skn-1 RNAi also did not increase 
apoptosis in single brap-2 mutants, skn-1 RNAi increased apoptosis in brap-2;brc-1 double 
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mutants to levels similar to the wild type (Figure 2.9C). This suggests that a loss of brap-2 may 
promote cell survival in brc-1 mutants, in part through SKN-1 activation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
A 
        
B 
 
C 
 
 
Figure caption on next page.  
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Figure 2.9: skn-1 RNAi knockdown increases apoptosis in brap-2;brc-1 double mutants 
following DNA damage  
 
(A) qRT-PCR was performed before and after DNA damage. Levels of skn-1c are elevated in 
brap-2 mutants following IR. Results represent 3 independent trials, normalized to act-1 of the 
wild type (N2). (B) Expression levels of apoptosis genes were measured in N2 worms fed with 
skn-1 RNAi. skn-1 knockdown was confirmed by quantifying skn-1c transcripts. A reduction in 
cep-1, egl-1, ced-13 and ced-9 levels was observed. Results represent 3 independent trials, 
normalized to act-1 of N2 (log2 scale). (C) Although skn-1 RNAi in the wild type does not affect 
apoptosis levels, skn-1 knockdown in brap-2;brc-1 increased apoptosis to levels similar to the 
wild type. Results represent 3-7 trials. Two trials were completed for brc-1(tm1145) and brap-
2(ok1492) on pL4440 at 0 Gy. Apoptotic cells were scored 24 hours post IR using AO. 
p<0.001***, p<0.01**, p<0.05*. 
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2.4.4 Loss of pmk-1 increases germline apoptosis in brap-2(ok1492) mutants  
Phosphorylation of SKN-1 by MPK-1 (ERK ortholog) and PMK-1 (p38 MAPK ortholog) 
kinases promote SKN-1 entry into intestinal nuclei and transcription of target detoxification 
genes to mount a defence against oxidative stress (36,37). Phosphorylated MPK-1 has been 
found to be required for apoptosis activation and the progression of pachytene nuclei to 
oogenesis (4,38). We previously found that brap-2(ok1492) mutants display a 1.5-fold increase 
in phosphorylated MPK-1. However, in brap-2(ok1492) mutants a loss of mpk-1 did not increase 
apoptosis after DNA damage exposure, and only reduced egl-1 mRNA levels (Figure S2.5).  
 In addition to SKN-1 activation, a loss of PMK-1 has been found to prevent arsenite 
induced germline apoptosis independently of CEP-1 (39). We next asked if PMK-1 was required 
for BRAP-2 regulation of DNA damage induced germline apoptosis. To determine whether 
PMK-1 activity is elevated in brap-2 mutants we measured the mRNA expression levels of two 
known PMK-1 target genes F35E12.5 (40) and F08G5.6 (41), expressed as part of the innate 
immune response to defend against bacterial pathogens (41–43). We found that brap-2 mutants 
have a significant PMK-1 dependent 4.5-fold and 5.3-fold (p<0.001) increased expression of 
F08G5.6 and F35E12.5 respectively (Figure 2.10A).  
We performed Western blot of worm lysates to quantify the levels of phosphorylated 
PMK-1 in brap-2 mutants. brap-2 mutants displayed a 1.41-fold increase in phospho-PMK-1 
compared to the wild type, indicating that brap-2 mutants may have an increase in activated 
PMK-1 (Figure 2.10B). Although a loss of pmk-1 reduced egl-1 and ced-13 mRNA levels by 
half, loss of pmk-1 in brap-2(ok1492) did not decrease the levels of these apoptotic genes (Figure 
S2.5B). We then asked if increased PMK-1 activity contributes to the reduced apoptosis in brap-
2 mutants following DNA damage exposure. To verify this, we scored apoptosis levels in brap-
77 
 
2;pmk-1 double mutants and found that a loss of pmk-1 in brap-2(ok1492) mutants elevated 
apoptosis to wild type levels (Figure 2.10C). Together, these results suggest that the reduction in 
apoptosis in brap-2(ok1492) mutants is dependent on PMK-1 activity and indicates that reduced 
levels of apoptosis previously seen in brap-2;brc-1 mutants, may be mediated in part by SKN-1 
through PMK-1 activation.  
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Figure caption on next page.  
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Figure 2.10: Loss of pmk-1 increased germline apoptosis in brap-2 mutants 
 
(A) qRT-PCR was used to measure PMK-1 activity by quantifying the levels of PMK-1 targets 
F08G5.6 and F35E12.5 (log10 scale). Transcript levels of both genes increased significantly in 
brap-2 mutants and was dependent on PMK-1. Results represent 3 independent trials, normalized 
to act-1 of the wild type (N2). (B) A 1.41-fold increase in phospho-p38 MAPK/PMK-1 intensity 
is seen in brap-2(ok1492) mutants compared to N2. N2 treated with 5 mM sodium arsenite was 
used as a positive control, while the pmk-1(km25) mutant was used as a negative control. Results 
represent 3 independent trials. Band intensity was measured in ImageJ, normalized to their 
respective α-tubulin levels and then compared to N2. Graph represents the average relative 
density of phosphorylated PMK-1 for each genotype. (C) Loss of pmk-1 in brap-2 mutants 
increased apoptosis to levels comparable to N2. Corpses were scored before and after IR using 
AO. Results represent 3 independent trials. p<0.001***, p<0.01**. 
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2.4.5 Interaction between PHLPP1 and BRAP2 in C. elegans is conserved 
 
BRAP2 is expressed in many tissues but is most enriched in mammalian testes (11). An 
Y2H (Yeast 2 Hybrid) screen using a human testes specific cDNA library uncovered several 
potential BRAP2 binding partners, and one protein uncovered was the AKT protein phosphatase 
PHLPP1 (11). AKT is a serine/threonine kinase responsible for promoting cell survival, growth 
and proliferation (44). AKT is inactivated by the removal of phosphate groups at two sites, 
Thr308 and Ser473 (45). PHLPP1 dephosphorylates AKT at Ser473 (46,47) and as a result 
completes AKT inactivation, preventing the inhibition of FOXO and other targets which promote 
cell death (48). The interaction between BRAP2 and PHLPP1 was determined to prevent 
PHLPP1 from reaching spermatocyte nuclei, indicating that BRAP2 may act as a PHLPP1 
binding protein (11).  
This was of interest to us since we found that BRAP-2 expression is conserved in the 
cytoplasm of the C. elegans hermaphrodite germline (Figure S2.1). In C. elegans, PHLP-2 
(F43C1.1) is orthologous to PHLPP1 and PHLPP2. Using a GST pull down assay and Western 
blot we found that BRAP-2 physically binds to PHLP-2, indicating that this interaction is 
conserved (Figure 2.11). We also found that a truncated form of BRAP-2, denoted as ΔCT-
BRAP-2 which mimics the ok1492 mutant protein and lacks the C-terminal region (removing the 
RING, Zinc Finger and coiled-coil domains) was also able to bind to PHLP-2. This indicates that 
the C-terminal portion of BRAP-2 is not necessary for this interaction. Therefore, it is possible 
that BRAP-2 may function to regulate the activation of the IIS/AKT pathway in C. elegans.  
 
 
 
 
 
 
81 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: Interaction between PHLPP1 and BRAP2 in C. elegans is conserved                   
 
Full length BRAP-2 interacts with PHLP-2. We found that a truncated form of BRAP-2, missing 
the C-terminus (ΔCT-BRAP-2), also binds to PHLP-2. Thus this interaction is conserved in C. 
elegans. Plasmids were co-transfected in 293T HEK cells, followed by a GST pull down and 
Western blot analysis. Result represents 3 independent trials.  
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2.4.6 brap-2 mutants are dauer defective  
 
Developmental arrest (dauer) is initiated by inactivation of IIS leading to inhibition of 
AKT-1 and AKT-2 (AKT orthologs), allowing DAF-16 (FOXO ortholog) to enter the nucleus 
for the transcriptional upregulation of pro-survival and dauer genes (49–51). Mutants of the IIS 
pathway can leave worms dauer constitutive and in a constant state of developmental arrest, or 
dauer defective where they are unable to initiate the arrested state for survival (50). While 
maintaining our brap-2(ok1492) strain, we observed that they did not appear to enter dauer when 
starved and previous work from our lab showed that brap-2(ok1492) mutants displayed no 
change in the expression levels of sod-3 (SOD3 ortholog), a DAF-16 target gene involved in 
phase I ROS detoxification (15). Thus we hypothesized that brap-2 mutants may increase IIS 
signaling leading to DAF-16 inactivation.  
To test this we performed a dauer defective assay (23), where following nutrient 
deprivation dauer worms were isolated with 1% Sodium Dodecyl Sulfate (SDS) treatment. We 
found that similar to daf-16(mu86) mutants, brap-2(ok1492) mutants were unable to survive SDS 
treatment (Table 2.1), indicating that the brap-2(ok1492) mutation may inhibit DAF-16, 
preventing worms from entering the dauer state. We also tested the effect of removing MPK-1, 
PMK-1, and AKT-1 and found that they rescued the brap-2 mutants and allowed them to enter 
dauer (Table 2.1). Interestingly, unlike AKT-1, a loss of AKT-2 in brap-2 mutants did not 
restore dauer entry. This suggests that BRAP-2 may function specifically through AKT-1, and 
not AKT-2 to inhibit DAF-16. 
Increased IIS signaling causes phosphorylation of DAF-16 preventing its nuclear 
accumulation in the intestine and targeted gene transcription (51). Since we observed brap-2 
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mutants to be dauer defective, we hypothesized IIS signaling is enhanced in brap-2 mutants, 
decreasing DAF-16 activity. To verify whether a loss of brap-2 causes increased IIS signaling, 
we used qRT-PCR to measure the mRNA expression levels of known targets of this pathway. 
INS-7 is an insulin/IGF-1 –like peptide (ILP) whose expression is elevated with increased IIS 
stimulation (52). Similar to daf-16 mutants, which exhibited increased ins-7 levels, brap-2 
mutants displayed a 2-fold increase in ins-7 expression (Figure 2.12A). We also measured the 
levels of the antioxidant enzyme and DAF-16 target, ctl-1 (CAT1 ortholog) and found that in 
brap-2 mutants ctl-1 mRNA levels were reduced 167-fold (p<0.01) (Figure 2.12B) (53).  
We also examined the localization of DAF-16 in vivo, using a DAF-16::GFP reporter 
strain in a brap-2(ok1492) mutant background. As a positive control for DAF-16 activation and 
nuclear accumulation, worms were treated with 5 mM sodium arsenite. We scored DAF-16::GFP 
expression in the intestine as cytoplasmic, intermediate or nuclear. We found that both before 
and following arsenite treatment, brap-2(ok1492) mutants displayed a reduction in nuclear 
accumulation and greater intermediate and cytoplasmic localization of DAF-16 in the intestine 
(Table 2.2). In addition, we also saw a modest increase in cytoplasmic DAF-16 localization in 
brap-2 mutants following 60 Gy of IR. Taken together these results suggest that BRAP-2 may 
regulate IIS signaling, where a loss of BRAP-2 may lead to increased DAF-16 inhibition by 
AKT-1, both physiologically and when exposed to exogenous stressors.  
 
 
 
 
 
 
 
 
 
84 
 
Table 2.1: brap-2 mutants are dauer defective 
brap-2(ok1492) mutants were unable to survive SDS treatment following starvation. Loss of 
mpk-1, pmk-1 and akt-1 but akt-2 allowed brap-2 mutants to enter dauer and survive SDS 
treatment. Plates were viewed under a dissection microscope and scored as “Thrashing” if worms 
were alive and moving in solution. This demonstrates selection for dauers due to their ability to 
resist SDS. Plates were scored as “Dead” if no worm movement in solution was observed.  
 
 
 
 
Strain 
 
N  
(Number of 
Plates)  
Thrashing  
(% N)  
Dead  
(% N) 
N2 70 100  0  
akt-1(ok525)  46 82.61 17.39 
akt-2(ok393) 46 65.22 34.78 
brap-2(ok1492) 61 0 100 
daf-16(mu86) 69 0 100 
mpk-1(ga111) 40 95 5 
pmk-1(km25) 48 100 0 
akt-1(ok525);brap-2(ok1492) 41 65.85 34.15 
akt-2(ok393);brap-2(ok1492) 42 4.76 95.24 
brap-2(ok1492);mpk-1(ga111) 44 90.91 9.10 
brap-2(ok1492);pmk-1(km25) 37 70.27 29.73 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
85 
 
 
A 
 
       
   
B  
 
     
    
 
 
Figure 2.12: brap-2 mutants have increased ins-7 and reduced ctl-1 mRNA levels 
 
(A) Using qRT-PCR we found that similar to daf-16(mu86) mutants, brap-2(ok1492) mutants 
expressed increased mRNA levels of ins-7, an insulin-like signaling peptide whose expression 
increases with increased IIS pathway stimulation. (B) ctl-1 (DAF-16 target gene) mRNA 
expression is significantly reduced in brap-2 mutants (log10 scale). Results represent 3 
independent trials, normalized to act-1 of the wild type (N2). p<0.001***, p<0.01**.  
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Table 2.2: brap-2 mutants have increased cytoplasmic DAF-16 localization 
Using a DAF-16::GFP reporter, we found that brap-2(ok1492) mutants displayed reduced 
nuclear accumulation, and increased cytoplasmic and intermediate distributions of DAF-16. 
Worms were scored as having either cytoplasmic, intermediate or nuclear distributions of DAF-
16. Representative images of wild type worms depicting cytoplasmic, intermediate and nuclear 
expression of DAF-16 in the intestine.  
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2.4.7 Loss of akt-1 increased apoptosis in brap-2 mutants 
akt-1 and akt-2 gain of function mutants have been found to suppress DNA damage 
induced germline apoptosis (54). Thus the promotion of cell survival through AKT activation in 
C. elegans is conserved. However, in this context AKT isoforms are predicted to function in 
distinct ways. AKT-1 is thought to inhibit CEP-1 transcriptional activation of egl-1 and ced-13, 
while AKT-2 functions to inhibit DAF-16 (55). Having found brap-2 mutants to be dauer 
defective and inhibit DAF-16 function, we hypothesized that BRAP-2 may function through 
AKT-1 to regulate DNA damage induced germline apoptosis.  
We generated an akt-1(ok525);brap-2(ok1492) double mutant strain and scored apoptosis 
following IR. We found that a loss of akt-1 in brap-2 mutants increased apoptosis to wild type 
levels (Figure 2.13A). Interestingly, although a loss of akt-2 in brap-2 mutants increased 
apoptosis, it was not as significant as a loss of akt-1. Knockdown of akt-1 using RNAi in both 
brap-2 and brap-2;brc-1 double mutants also increased apoptosis to wild type levels following 
DNA damage (Figure 2.13B). However, removal of DAF-16 did not increase apoptosis in brap-
2(ok1492) mutants indicating that DAF-16 was not required. Together, these results indicate that 
AKT-1 is at least partially required for the decrease in germline apoptosis seen in brap-2 mutants 
upon IR, in a daf-16 independent manner. 
Having observed that brap-2 mutants reduced DAF-16 nuclear accumulation and require 
AKT-1 for reduced levels of germline apoptosis following DNA damage, we predicted AKT-1 
protein would be increased in brap-2(ok1492) mutants. We quantified akt-1 mRNA expression 
levels in brap-2 mutants and found that akt-1 levels in brap-2 mutants increased 2.2-fold (Figure 
2.14A). We also found that the levels of endogenous AKT-1 in brap-2 mutants increased 1.43-
fold, while phlp-2 mutants produced no change in AKT-1 levels (Figure 2.14B).  
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De-phosphorylation of AKT by PHLPP1 inactivates AKT preventing downstream AKT 
function that leads to cell survival, growth and proliferation (47). We hypothesized that a loss of 
PHLP-2 would allow for persistent AKT-1 activation and cause a reduction in germline 
apoptosis following DNA damage exposure. We found that phlp-2(tm7788) mutants displayed a 
4.5-fold reduction in apoptosis following IR compared to the wild type (Figure 2.15A). At the 
same time, apoptosis levels in phlp-2 mutants were also lower than the wild type physiologically, 
indicating that PHLP-2 is required for the general activation of apoptosis. We also found that 
phlp-2 RNAi knockdown moderately reduced apoptosis in brc-1 mutants (Figure 2.15B). To 
determine whether PHLP-2 is required for the activation of apoptosis in akt-1 mutants we 
generated an akt-1(ok525);phlp-2(tm7788) double mutant strain and found that again a loss of 
phlp-2 significantly reduced apoptosis following IR (Figure 2.15A).  
Reduced apoptosis in PHLP-2 mutants indicates that like BRAP-2, PHLP-2 is required to 
promote germline apoptosis. However, these findings also suggest that PHLP-2 may be required 
to regulate other proteins besides AKT-1 in this context. Therefore, these findings suggest that 
BRAP-2 may function through AKT-1 to regulate DNA damage induced germline apoptosis, 
where increased AKT-1 activation caused by a loss of brap-2 may promote cell survival. 
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Figure 2.13: Loss of akt-1 increases apoptosis in brap-2 mutants 
(A) Loss of akt-1 significantly increased apoptosis in brap-2 mutants to levels similar to the wild 
type (N2), following IR. While no change in apoptosis levels was observed in brap-2 mutants 
with the loss of daf-16. Results represent 3 independent trials. (B) akt-1 RNAi in brap-2;brc-1 
mutants increased apoptosis to levels similar to N2 following IR. Results represent 3 independent 
trials. Two independent trials were completed for brc-1;daf-16 mutants. Germline corpses were 
scored using AO. p<0.01**, p<0.05*. 
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Figure 2.14: AKT-1 is elevated in brap-2(ok1492) mutants  
 
(A) Using qRT-PCR brap-2 mutants display a 2.2-fold increase in akt-1 mRNA expression. 
Results represent 3 independent trials, normalized to act-1 of the wild type (N2). (B) brap-
2(ok1492) mutants displayed a 1.43-fold increase in AKT-1 protein levels. Endogenous AKT-1 
levels were detected using α-AKT-1 128 and α-AKT-1 527 antibodies, recognizing the C-
terminal region. Band intensity was measured using ImageJ and normalized to their respective α-
tubulin levels and then to N2. Graph represents the average relative density of endogenous AKT-
1 levels for each genotype. Result represents 3 independent trials. p<0.05*. 
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Figure 2.15: Loss of phlp-2 reduced germline apoptosis in akt-1 mutants  
(A) phlp-2 mutants displayed a significant reduction in apoptosis before and after IR. Loss of 
phlp-2 also significantly reduced apoptosis in akt-1 mutants following IR. (B) phlp-2 RNAi 
caused a modest reduction in apoptosis in the wild type and brc-1 mutants. Two independent 
trials were completed for pL4440 and 3 independent trials for phlp-2 RNAi. Germline corpses 
were scored using AO. p<0.001***, p<0.05*. 
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2.5 Discussion  
The work presented here identifies a new role for BRAP-2 in DNA damage induced 
germline apoptosis through the regulation of the transcription factor SKN-1 and the protein 
kinase AKT-1. The C. elegans germline possesses highly conserved mechanisms of the DNA 
damage response, where a loss of BRC-1 leads to a failure in DNA repair and increased germline 
apoptosis (8). We have shown that brap-2(ok1492) mutants cause a reduction in germline 
apoptosis in response to DNA damage induced by IR, and high levels of germline apoptosis in 
brc-1 mutants is dependent on BRAP-2.  
Previously, we found that brap-2(ok1492) mutants increased SKN-1/Nrf2 localization 
into intestinal nuclei and increased SKN-1 dependent phase II detoxification gene expression 
(15). Here we have shown that skn-1 mRNA levels remain elevated in brap-2 mutants after DNA 
damage, and skn-1 RNAi reduced the expression levels of apoptosis genes. ChIP (Chromatin 
Immunoprecipitation) of SKN-1 binding sites conducted by the Snyder Lab, has predicted that 
SKN-1 binds to the promoters of egl-1 and ced-13, and is most enriched at the promoter of mev-
1, which is upstream and part of the operon that regulates ced-9 transcription (modENCODE). 
This indicates that SKN-1 may have the potential to act as a transcriptional regulator of the core 
apoptotic pathway.  
SKN-1 is provided maternally during embryogenesis, yet SKN-1 protein has not yet been 
detected in adult hermaphrodite germlines, nor does the loss of SKN-1 alter the levels of 
apoptosis in wild type worms (31,56). We found that skn-1 RNAi increased apoptosis only in 
brap-2;brc-1 double mutants, and although we did not detect any defects in the germline 
directly, we cannot rule out that increased apoptosis in these double mutants may be due to 
germline instability with a loss of both brc-1 and skn-1. However, in this context it may be 
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possible for a intestine-germline interaction in which SKN-1 has a cell survival role in the 
germline apart from it responding to oxidative stress that may be similar to Nrf2, which has been 
shown to have a pro-survival role in cancer development through its upregulation of anti-
apoptotic genes, promotion of an unaltered metabolism and changes to ubiquitin-proteasome 
protein turnover (57).  
A loss of brap-2 caused a CEP-1 dependent increase in expression of pro-apoptotic genes 
egl-1 and ced-13, which were even greater when exposed to DNA damage, suggesting a potential 
role for BRAP-2 as a negative regulator of CEP-1. Several genes have been found to regulate 
apoptosis such as eel-1, sir-2.1 and kri-1, all of which display pro-apoptotic function independent 
of CEP-1 (31,58,59). We determined that brap-2 mutants displayed elevated PMK-1 activity, 
and a loss of pmk-1 (but not mpk-1) increased apoptosis in brap-2 mutants to wild type levels 
following IR. Interestingly, while a loss of both these kinases decreased egl-1 and ced-13 
expression, a loss of mpk-1 was only able to reduce egl-1 levels in brap-2 mutants. This indicates 
that PMK-1 and MPK-1 may influence CEP-1 activity, but increased levels of these apoptotic 
genes in brap-2 mutants does not directly dictate apoptosis induction. Thus we predict that brap-
2 may also act as a pro-apoptotic gene that regulates DNA damage induced apoptosis through 
pathways parallel to the core apoptotic program. We believe that BRAP-2 regulates apoptosis in 
part through the PMK-1/p38 MAPK pathway which is known to activate SKN-1 and is 
associated with oxidative stress and immune responses (36,39,60).  
AKT-1 and AKT-2 regulate apoptosis through two distinct mechanisms, and dimerize to 
phosphorylate and inhibit DAF-16 preventing dauer formation (54). We found that a loss of akt-
1 more significantly increased apoptosis in brap-2 mutants than a loss of akt-2, in a daf-16 
independent manner. Although we were unable to test phosphorylated AKT-1 levels to verify 
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whether increased endogenous AKT-1 protein levels in brap-2(ok1492) mutants corresponded to 
increased AKT-1 activation, we have found that a loss of brap-2 enhanced IIS stimulation and 
DAF-16 attenuation, seen with the increased intermediate and cytoplasmic distribution of DAF-
16 in the intestine and a reduction in DAF-16 target expression.  
We also confirmed that BRAP-2 interacts with PHLP-2 in vitro, placing BRAP-2 as a 
potential regulator of the IIS pathway. We have shown that phlp-2 is required for apoptosis 
activation in akt-1 mutants, and that phlp-2 mutants display a significant reduction in germline 
apoptosis. Although we did not see elevated levels of endogenous AKT-1 in phlp-2 mutants, we 
cannot assume levels of activated AKT-1 are not increased with phlp-2 inactivation. Therefore, 
we postulate that AKT-1 and SKN-1 activity are modulated by BRAP-2 for regulation of DNA 
damage induced germline apoptosis. Similar to brap-2, further investigation is required to 
determine whether the IIS or an alternative pathway is activated in phlp-2 mutants. However, we 
were able to show that phlp-2 mutants displayed a significant and general reduction in apoptosis, 
and thus have identified a potential novel role for PHLP-2 in germline apoptosis. 
Previous studies have determined that ubiquitin ligases SCFFSN-1 and EEL-1 are also 
regulators of germline apoptosis (31,61). Like its mammalian ortholog, BRAP-2 possesses 
conserved functional domains of an E3 ubiquitin ligase. We did not verify whether functionally 
this enzymatic activity is conserved however, it cannot be ruled out as a possible mechanism to 
post translationally modify proteins such as PHLP-2 to regulate their activity and affect the 
downstream signaling of these pathways. Our findings suggest that BRAP-2 regulates DNA 
damage induced germline apoptosis, wherein BRAP-2 blocks the activation of pro-cell survival 
pathways to promote apoptosis, by inhibiting SKN-1 and AKT-1 through the p38 MAPK 
pathway and PHLP-2 respectively (Figure 2.16).  
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Programmed cell death is vital for shaping organs and limbs, eliminating self-reactive 
cells and for protection against malignant transformation that can lead to tumor formation and 
cancer. Here we have uncovered a new role for BRAP-2 and its potential for regulating both 
SKN-1 through the PMK-1/p38 MAPK pathway, and AKT-1 to regulate C. elegans germline 
apoptosis. Although further investigation is needed, we also revealed a potential novel role for 
PHLP-2, where it may be necessary for the general induction of C. elegans germline apoptosis. 
We did not detect a conserved physical interaction between BRC-1 and BRAP-2, and thus do not 
know if BRAP2 functions to promote apoptosis in higher organisms in the same way as we have 
observed with BRAP-2 in the C. elegans germline. Although to our knowledge a role for BRAP2 
has not be identified for the regulation of programmed cell death, our previous findings that 
BRAP-2 acts as a regulator of the oxidative stress response through regulation of SKN-1/Nrf2, 
and our work presented here reveals BRAP-2 as a potential conserved binding protein for PHLP-
2 and regulator of AKT-1. We would predict that if enhancement of these pathways is observed 
with BRAP2 inactivation they could function together to prevent apoptosis and enhance cell 
survival. The evasion of programmed cell death is a hallmark of cancerous cells, and this has 
provided us with a genetic tool that will allow us to better understand the complex and intricate 
regulation of signaling pathways that govern the balance between pro-death and pro-cell survival 
factors that lead to apoptosis activation, while discovering potential new targets that regulate 
apoptosis for future study and therapeutic development.  
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Figure 2.16: Proposed model for BRAP-2 regulation of DNA damage induced germline 
apoptosis.  
 
Schematic diagram depicting a proposed mechanism for BRAP-2 regulation of DNA damage 
induced germline apoptosis. Our findings suggest that BRAP-2 regulates DNA damage induced 
germline apoptosis through a non-canonical signaling mechanism, regulating pro-cell survival 
pathways to promote apoptosis by inhibiting SKN-1 and AKT-1, through the PMK-1/p38 MAPK 
pathway and potentially PHLP-2, respectively. Dashed lines represent hypothesized interactions.  
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2.6. Supplementary Figures 
A 
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Figure S2.1: BRAP-2 is expressed in the germline cytoplasm following DNA damage 
  
(A) Adult wild type (N2) and brap-2(ok1492) mutant germlines were immunostained with α-
BRAP-2 antibody. We found BRAP-2 to be expressed in the cytoplasm of the germline, 
surrounding nuclei in both N2 and brap-2 mutants. (B) Following 60 Gy, BRAP-2 is still found 
to be expressed in the N2 germline cytoplasm. Representative images of 10 extruded germlines. 
Due to the large size, image presented is a composite of two images taken of the same gonad. 
White arrows indicate germline. Yellow arrows indicate intestine.  
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Figure S2.2: Genomic structure of brap-2 and deletion mutant ok1492  
(A) Located on Chromosome II, the brap-2 gene is comprised of 8 exons with a total length of 
2693 bp. Its coding sequence is 1773 bp. (B) This study focused on the brap-2(ok1492) mutant 
that possesses a 1540 bp deletion in the C-terminal end which removes exons 5-8 but leaves 15 
bp untouched at the end. Gene depictions are not to scale. Genomic structures were adapted from 
Wormbase and Koon and Kubiseski (2).   
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Figure S2.3: brap-2 mutants display reduced levels of germline apoptosis following DNA 
damage 
 
(A) We scored the levels of apoptosis using a ced-1p::GFP reporter strain in a brap-2(ok1492) 
mutant background. We found that following DNA damage, brap-2 mutants experience a 50% 
reduction in germline apoptosis. (B) Representative images of the ced-1p::GFP reporter strain 24 
hours post IR. A significant reduction of apoptosis was observed in brap-2(ok1492) mutants 
compared to the wild type. Yellow arrows indicate apoptotic cells (outlined by GFP halo). 
Results represent 3 independent trials. p<0.001***. 
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Figure S2.4: A loss of brc-1 extends brap-2(ok1492) mean survival  
 
(A) At 0 Gy brap-2(ok1492) experiences a mean survival of 11.67 ± 1.67 days compared to the 
wild type (N2) wildtype of 13.3 ± 0.67 days. brap-2 mutant survival was extended to 13.0 ± 1.0 
days with the loss of brc-1. (B) Following 60 Gy, brap-2(ok1492) experiences a mean survival 
of 8.33 ± 0.67 days compared to N2 of 9 ± 0.57 days. Survival of brap-2(ok1492) mutants is 
extended with the loss of brc-1 to 10 days. Synchronized worms of each genotype were plated in 
quadruplicates, 15-20 worms were followed from the 1st day of adulthood to their death. Graph 
represents one of 3 independent trials.  
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Figure S2.5: Loss of mpk-1 did not increase apoptosis in brap-2 mutants 
 
(A) Loss of mpk-1 in brap-2(ok1492) mutants did not increase apoptosis following DNA 
damage. Result represents 3 independent trials. (B) mpk-1 and pmk-1 mutants displayed a 
reduction in egl-1 mRNA levels. A loss of mpk-1, but not pmk-1, reduced egl-1 mRNA 
expression levels in brap-2(ok1492) mutants. (C) A loss of either mpk-1 or pmk-1 did not reduce 
ced-13 mRNA levels in brap-2(ok1492) mutants. Results represent 3 independent trials, 
normalized to act-1 of the wild type (N2). p<0.001***, p<0.01**, p<0.05*. 
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3.1 Summary 
Mutations in C. elegans can produce visible and quantifiable defects in morphology, 
lifespan and development. Along with its high genetic conservation, it provides us with an 
exceptionally useful model for the study of human disease-related gene function. BRC-1 
(BRCA1 ortholog) mutant animals look and develop similar to the wild type, but possess 
defective DNA repair, increased germline apoptosis and greater embryonic lethality (1). 
BRAP2/IMP (BRCA1-associated binding protein 2) has been characterized as an E3 ubiquitin 
ligase and as a cytoplasmic retention protein (2–4). It has also been found to be widely expressed 
throughout various mammalian tissues, most highly in testes (4). However, its role in the 
development or health of these tissues has not been addressed. The focus of this study is to 
determine the role of BRAP-2 in C. elegans morphology, development and germline integrity. 
Previously, we have found that the C. elegans BRAP2 ortholog BRAP-2, is involved in the 
regulation of oxidative and DNA damage stress responses. We have determined that brap-2 
mutants display defects in morphology, delayed life cycle progression, and a reduction in brood 
size and survival. Furthermore, embryonic lethality and sterility is elevated in brap-2 mutants 
following DNA damage, suggesting a potential role for BRAP-2 in facilitating DNA repair. We 
have also found that a loss of brap-2 reduced sperm quality and reduced male production in him-
5 (High incidence of males) mutants. Our findings suggest that BRAP-2 is required for C. 
elegans development, survival and overall germline health.  
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3.2 Introduction 
C. elegans is a powerful model organism due to its simplicity and high genetic 
conservation with mammalian disease genes and subsequently many cell signaling pathways. It 
is a tiny, transparent hermaphroditic nematode that possesses an invariant number of somatic 
cells (5). One of the many benefits of this model is that it has a short generation time, reaching 
adulthood in 3 days, produces a large number of progeny (~300) in every generation and can live 
up to 2 weeks (5). Genetic screens have uncovered the involvement and function of many 
conserved human genes, dissecting the genetic order of signaling cascades that execute stress 
responses, programmed cell death and control development (6). Novel gene mutations can alter 
C. elegans development or produce visible phenotypes in morphology, which can implicate their 
involvement in disease-associated signaling pathways.  
The germline is the only continuously proliferative tissue in C. elegans, where mitotically 
proliferating cells eventually become oocytes after meiosis prophase I progression which begins 
at the transition zone (TZ), followed by meiotic recombination in pachytene and diakinesis (7). 
The germline also employs mitotic arrest, DNA repair and apoptosis in spatially distinct areas to 
protect nuclei from the threat of external and internal stressors for successful meiotic 
progression, gametogenesis and self-fertilization (8,9). Mutations in genes involved in 
coordinating and executing the DNA damage response (DDR) can exhibit defects in embryonic 
lethality, chromosome morphology and radiation sensitivity (9). BRCA1 (Breast cancer 
susceptibility gene 1) is a tumor suppressor that participates in several DNA damage surveillance 
mechanisms including DNA repair, transcription and cell cycle arrest (10). Although worms 
appear normal, loss of BRC-1 (BRCA1 ortholog) causes an increase in germline apoptosis, 
increased RAD-51 (RAD51 ortholog) foci formation at double strand break (DSBs) sites, 
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increased embryonic lethality, as well as X chromosome non-disjunction increasing the 
incidence of males (1,11). Thus the continued maintenance and protection of the germline is vital 
for C. elegans development and survival.  
BRAP2 (BRCA1-associated binding protein 2 or BRAP according to the HUGO 
database) is an E3 ubiquitin ligase and is characterized as a cytoplasmic retention protein due to 
its ability to prevent BRCA1 nuclear import (12). BRAP2 has been found to interact with other 
proteins and prevent their nuclear localization, most notably p21, CDC14 and PHLPP1 
(3,2,13,4). BRAP2 has also been identified as a RAS effector that upon activation of RAS, is 
auto-ubiquitinated, releasing KSR for increased ERK activation (14–16). Previously, we 
characterized the C. elegans BRAP2 ortholog BRAP-2, and found that brap-2 mutants 
experience BRC-1 dependent L1 developmental arrest when exposed to oxidative stress (17). In 
addition, we found that BRAP-2 is a potential negative regulator of SKN-1 (C. elegans Nrf2 
ortholog), master regulator of the phase II detoxification response (18). We also determined that 
BRAP-2 promotes DNA damage induced germline apoptosis, a vital component of the DDR.  
We previously confirmed that brap-2(ok1492) mutants are dauer defective, and while 
maintaining the brap-2 mutant strain we also observed that they grew more slowly and their 
morphology was distinct to the wild type. The focus of this study was to determine the effects a 
loss of BRAP-2 has on C. elegans morphology, development and survival as well as examine the 
potential importance of BRAP-2 in maintaining germline integrity. We have found that brap-2 
mutant animals are shorter in length, possess a developmental delay and have reduced mean 
survival. brap-2 mutants also have reduced brood size and sperm quality, and following DNA 
damage induced by ionizing radiation (IR), have increased radiation sensitivity in mitotic nuclei. 
This suggests that BRAP-2 is required for proper C. elegans development and germline health.  
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3.3 Materials & Methods  
3.3.1 C. elegans strains and genetics  
All worm strains were cultured under standard conditions, as previously described (19). All 
strains were obtained from the Caenorhabditis Genetics Center located at the University of 
Minnesota and double mutant strains were generated using standard protocols. The N2 Bristol 
strain was used as the wild type, and unless noted otherwise all experiments were conducted at 
20°C. Strains were sequenced at Sick Kids TCAG for the presence of him-5(e1490). The 
following strains were used in this study: N2, brap-2(ok1492) II (YF15), brc-1(tm1145) III 
(DW102), brap-2(ok1492) II; brc-1(tm1145) III (YF64), brap-2(ok1492)/mIn 1 [MIs14dyp10 
(e128)] II [denoted as brap-2(ok1492)/+] (YF104), him-5(e1490) V (DR466), brap-2(ok1492) II; 
him-5(e1490) (YF195), BRAP-2::GFP (YF199).  
3.3.2 Brood size and embryonic lethality 
To assess brood size, 5 adult worms for each genotype were plated per Nematode Growth Media 
(NGM) plate in triplicate. Adult worms were allowed to lay eggs for 5 hours at 3 permissive 
temperatures (16°C, 20°C and 25°C) and then removed. Eggs were scored, and the following day 
the number of unhatched eggs and L1 larvae were counted to assess both brood size, number of 
males and embryonic lethality.  
3.3.3 Developmental timing to adulthood 
Five adult worms for each genotype were plated per NGM plate in triplicate, allowed to lay eggs 
and then removed. For each strain, development to each larval stage was recorded every day 
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post-hatching on NGM plates (denoted as Day 0). Progression to each larval stage was recorded 
until the first day of adulthood was reached.   
3.3.4 Fluorescence Microscopy 
For each genotype, worms were synchronized and when they reached the first day of adulthood 
were mounted on 2% agarose in 2 mM Levamisole (Sigma L9756) in M9 Buffer. To examine 
worm length, width, male sensory rays and the BRAP-2::GFP reporter strain images were taken 
using a Zeiss LSM 700 Confocal Laser-Scanning Microscope with Zen 2010 Software. Length 
and width were measured using the line measurement tool in Zen 2010 Lite Software.  
3.3.5 Survival Analysis 
Synchronized worms were raised at 20°C and survival was scored beginning on the first day of 
adulthood and compared to non-irradiated controls. Worm survival was scored every 2 days, 
with worms pronounced dead using the “poke test”, if no response at the head or tail was 
produced to gentle prodding. Missing worms or those that developed “bag of worms” phenotype, 
were censored from the analysis. Worms were transferred to fresh NGM plates every 2 days.  
3.3.6 DNA Staining  
To quantify germline nuclei, whole worms were stained with DAPI as previously described (9). 
Z-stack images were taken at 63X and the Zen 2010 Lite software free-form surface area 
measurement tool was used to measure gonad surface area of one representative slice. To 
compare meiotic progression, germlines were dissected and stained with DAPI (VECTOR Labs 
H-1200). The ImageJ Cell Counter plugin was used to determine the total number of nuclei per 
zone in one gonad arm per worm per genotype imaged and scored. For chromosomal 
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fragmentation, Z-stack images of terminal oocytes at the -2 and -1 positions at the proximal end 
where examined for manual counting of condensed chromosome bodies.  
3.3.7 Gonad dissection and immunofluorescence in worms 
Gonad dissection and immunostaining was performed as previously described by (20), with the 
following changes: Approximately 20-30 synchronized 1 day old adults were mounted onto 20 
µL of 2mM Levamisole in M9 buffer on Superfrost Polylysine (Fisher 12-55505-15) coated 
slides in an area made with Immaedge Hydrophobic Pen (VECTOR Labs H-4000). The heads or 
tails were removed using 27G syringe needles in a “scissor-like motion”. Then 2% 
paraformaldehyde was added, coverslip was mounted and slides were allowed to sit for 10 
minutes and then frozen on an aluminum block on dry ice for 10 minutes. Slides were then freeze 
cracked using a razor blade and submerged in -20°C methanol for fixation for 1 minute. 
Following methanol fixation, slides were washed with 1X PBST (PBS, 0.1% Triton X-100) 3X 
for 5 minutes, followed by incubation for 1 hour in 2% BSA for 1 hour in a humid chamber. 
Primary antibody (prepared in 2% BSA) was added overnight at room temperature. Slides were 
washed 3X with 1X PBST and then secondary antibody was added dropwise and incubated for 1 
hour at room temperature in a humid chamber in the dark. Slides were washed 4X with 1X PBST 
for 5 minutes and in the third wash 1 µg/ml DAPI was added. Before mounting, 3 µL of Prolong 
Gold Anti-Fade Reagent (Life P36930) was added and coverslips were sealed using clear nail 
polish. Images of 10 fluorescent worms per genotype were taken. Antibodies used were: rabbit 
anti-BRAP-2 (1:100) and DAPI. Alexa Fluor 488 (1:1000) (Invitrogen A11001) secondary 
antibody was used. Rabbit polyclonal anti-sera against C. elegans BRAP-2 (EEED8.16) was 
generated by the Toronto Recombinant Antibody Centre of the University of Toronto using a 
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GST fusion protein with BRAP-2 antigen corresponding to residues 108 to 134, which lie in the 
N terminus of the protein. 
3.3.8 Generation of BRAP::GFP transgenic strain  
The transgenic strain BRAP-2::GFP was generated as described previously (21). The 5'HR arm 
was amplified using a fosmid template and sub-cloned into NaeI/SalI site of pDD282 (Addgene) 
using the HiFi Assembly Kit (NEB). 3'HR arm, using the fosmid template was then sub-cloned 
into pDD282 in SpeI and AvrII site to create the final plasmid. The single guide RNA (sgRNA) 
was designed manually and used to mutate the pDD162 (Addgene) vector.  
3.3.9 Cell transfection and immunofluorescence 
Human Embryonic Kidney (HEK) cells were used to examine BRAP-2 cellular localization. 
HEK cells were cultured in Dulbecco’s Modified Eagle’s Medium supplemented with 10% Fetal 
Bovine Serum. Cells were co-transfected for 24 hours, with 1 µg DNA of mammalian expressing 
constructs using polyethylenimine (PEI) (Sigma 408727-100 mL) and Optimem (Clontech 
31985). Cells were washed with PBS and then fixed with 4% paraformaldehyde for 15 minutes. 
Cells were permeabilized with 0.1 % Triton-X 100 for 5 minutes and then washed 3X with 1X 
PBST. Cells were incubated with 4% BSA for 1 hour in a humid chamber at room temperature. 
Cells were then incubated with primary antibody (in 4% BSA) for 1 hour at room temperature, 
and then washed 3X with 1X PBST. Secondary antibody (in 4% BSA) was then added for 1 hour 
at room temperature in the dark and then wash 3X with 1X PBST. In the third wash, 1 µg/mL 
DAPI was added. Coverslips were mounted onto plain glass slides with 3 µL of Pro-long Gold 
Anti-Fade Reagent and edges were sealed with clear nail polish. Z-stack images of cells were 
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taken using at 40X. The following antibodies were used: rabbit anti-GST (1:100), and Alexa 
Fluor 555 (1:200) for fluorescence visualization.  
3.3.10 RNA Isolation and Quantitative Real Time PCR (qRT-PCR) 
Worm RNA Isolation and qRT-PCR was performed as previously described (18). For each 
genotype, 100 µL of packed mixed-stage worms (IR treated and untreated controls) were 
collected and washed with M9 buffer 3X unless extraction occurred immediately, samples were 
frozen at -80ºC. RNA was extracted with TRI Reagent (Sigma #93289) as follows: Pelleted RNA 
was recovered with RNase-free water and residual DNA was digested using the DNA-Free Kit 
(Ambion AM1906). Total RNA concentration was measured using NanoDrop2000 and 0.5 µg of 
RNA was used to prepare cDNA following the manufacturer’s protocol using the RNA to cDNA 
kit (Applied Biosystem #4387406). To quantify mRNA levels, qRT-PCR was performed using 
SYBR green premix (Clontech #693676)/SensiFast SYBR Green (FroggaBio BIO-98005) and 
the Qiagen Rotor-Gene Q System (Qiagen R0511133). Data were derived from 3 biological 
replicates. Data analysis was performed using the Applied Biosystems Comparative CT Method 
(ΔΔCT Method). mRNA expression levels of each strain was compared relative to the wild type 
(N2) control, where the housekeeping gene act-1 (Actin) was used as the endogenous control for 
normalization. To verify equal primer amplification efficiency a standard curve for each set of 
primers was constructed using a serial dilution of cDNA. Using the qPCR Efficiency Calculator 
(ThermoFisher), amplification efficiency (%) of the qPCR reaction was determined based on the 
R2 value and the slope of the standard curve. 
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2.3.11 Radiation Sensitivity 
Synchronized L4 worms were irradiated at 60 and 120 Gy. Approximately 18-20 hours later, five 
1 day old hermaphrodites were transferred to NGM plates and allowed to lay eggs for 5 hours 
(with eggs laid corresponding to nuclei in the pachytene region) and were counted. The 
following day the number of unhatched eggs were scored. To determine L1 sterility, L1 stage 
worms were irradiated at 60 Gy, embryonic lethality of F1 adult progeny was assessed to 
determine sterility of these IR treated animals (22). 
3.3.12 Mating Assay  
To determine sperm quality, we performed a mating assay as previously described (23) with the 
following changes: 3 males and one L4 stage wildtype hermaphrodite were placed on NGM 
plates with a small spot of OP50 in the center and allowed to mate for 48 hours. Adult worms 
were then removed and brood size was quantified. Embryonic lethality was scored the following 
day. Two days later, the number of males and XXX hermaphrodites were scored. XXX 
hermaphrodites were identified due to their “dumpy” appearance. Assays were completed in 
triplicate and plates that produced zero male progeny were excluded from analyses.  
3.3.13 Statistical Analysis 
Statistical analysis was performed with GraphPad Prism 5 Software. Student’s t-test was 
performed when comparing two means. P values of <0.05 were taken to indicate statistical 
significance. Error bars represent +/- standard error of the mean.  
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3.4 Results 
3.4.1 BRAP-2 is expressed in the C. elegans germline 
Previous functional studies of BRAP2 in mammalian cell culture have determined that 
BRAP2 is localized to the cytoplasm, interacting with a variety of proteins where it has been 
found to generally retain and prevent their nuclear localization (3,4,13). One study found that 
BRAP2 is expressed in liver, heart and lung tissues but is most highly expressed in testes (4). We 
wished to determine whether localization and expression of BRAP-2 (BRAP2 ortholog) is 
conserved in C. elegans. To determine BRAP-2 subcellular localization in vitro we transfected a 
mammalian expressing construct with BRAP-2 in 293T HEK cells and found that like BRAP2, 
BRAP-2 exhibited a cytoplasmic localization (Figure 3.1).  
Previously, using α-BRAP-2 antibody we performed whole-worm antibody staining and 
detected a high level of BRAP-2 expression in the gonad of wild type worms. We took this one 
step further and immuno-stained wild type extruded germlines with α-BRAP-2 and found 
BRAP-2 to be localized in the cytoplasm surrounding germline nuclei, producing a “honeycomb 
effect” (Figure 3.2A). While examining BRAP-2 expression, we detected few germlines with 
BRAP-2 expression in the sperm sac (part of the somatic gonad, at the most proximal end of the 
germline before the uterus) (Figure 3.2B). Using the CRISPR-Cas9 system as previously 
described (21), we generated a BRAP-2::GFP transgenic strain to examine BRAP-2 expression 
in vivo. Again, we found BRAP-2 to be expressed throughout the germline, as well as in the 
sperm sac, and within embryos held in the uterus (Figure 3.3). Therefore, the cytoplasmic 
localization and high expression within the germline is conserved in C. elegans. Therefore it is 
possible that BRAP-2 function may be necessary for germline protection and development.  
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Figure 3.1: BRAP-2 localizes to the cytoplasm of mammalian 293T HEK cells  
 
GST::BRAP-2 was transfected into 293T HEK cells for 24 hours, fixed, probed with α-GST and 
stained with DAPI to detect BRAP-2 expression. Cells transfected with GST alone was used as a 
negative control. Representative images represent 3 independent trials.  
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Figure 3.2: BRAP-2 is expressed in the cytoplasm of the germline  
 
(A) Representative image of extruded wild type adult germlines stained with α-BRAP-2 
antibody, found BRAP-2 to be highly expressed in the cytoplasm of the germline, exhibiting a 
“honeycomb” effect with BRAP-2 expression surrounding germline nuclei. Ten one day old wild 
type adult worms were dissected and extruded germlines were examined. White arrows indicate 
the germline, while yellow arrows indicate the intestine of the worm. (B) BRAP-2 is expressed 
in the sperm sac of wild type hermaphrodite germlines. Representative image depicting BRAP-2 
expression in the sperm sac overlying nuclei in the wild type germline. BRAP-2 was detected in 
the sperm sacs of three extruded wild type adult germlines. White arrows indicate the sperm sac 
located at the proximal end of the gonad.  
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Figure 3.3: BRAP-2 expression is localized to the germline in vivo 
 
BRAP-2 expression was examined in vivo using a BRAP-2::GFP transgenic strain, generated 
using CRISPR-Cas9 (21). Representative image of exhibiting BRAP-2 expression in the 
germline of an adult worm. White arrows indicate Texas Red auto-fluorescence of the intestine 
that does not overlap BRAP-2::GFP expression. Ten one-day old adults were examined.  
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3.4.2 BRAP-2 is required for C. elegans survival and development  
C. elegans is a small, transparent roundworm ideal for genetic studies as defective 
phenotypes caused by mutation can be visualized directly. We examined whether brap-2 mutants 
possessed any developmental or morphological defects. Upon inspection it was apparent that the 
morphology of brap-2(ok1492) mutant worms differed from the wildtype. First, we found that 
brap-2(ok1492) mutants exhibited reductions in worm body length and width, of 100 µm and 10 
µm respectively (Figure 3.3).  
The C. elegans life cycle is short, reaching adulthood after 3 days at 20°C after 
progressing through four larval stages (L1-L4), distinguished by increasing size. If worms 
encounter stress in their environment they can exit the life cycle and enter an alternative L3 stage 
of developmental arrest (dauer), and survive harsh conditions for months (24). When 
environmental conditions become favorable, worms can re-enter the active life cycle and 
continue their development normally (25). Previously, we found that brap-2(ok1492) mutants are 
dauer defective and unable to developmentally arrest when starved. First, we examined the 
timing of development through each larval stage of brap-2 mutants and found that compared to 
the wild type, brap-2(ok1492) mutants experienced a developmental delay. Only 10% of brap-2 
mutants reached adulthood after 3 days, and 63% reaching adulthood after 4 days compared to 
the wild type (Figure 3.5).  
The average wild type C. elegans lifespan typically lasts up to 2 weeks. Long lived daf-2 
mutants of the IIS pathway can prolong worm lifespan 2-fold, while skn-1 mutant animals reduce 
mean survival 25-50% (26–28). Since we previously determined that in the context of DNA 
damage induced germline apoptosis BRAP-2 may act as a regulator of both IIS and the SKN-
1/Nrf2 oxidative stress pathway through p38 MAPK/PMK-1, we sought to determine whether a 
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loss of BRAP-2 affects worm survival. We found that brap-2(ok1492) mutants displayed a 
modest reduction in mean survival, and lived to an average of 11 days compared to the wild type 
of 13 days (Figure 3.5C). However, we previously found that with the loss of BRC-1 brap-
2(ok1492) survival can be extended to resemble the wild type. Taken together these results 
suggest that BRAP-2 is required for normal worm morphology, development and survival.  
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Figure 3.4: brap-2(ok1492) worms possess reduced body length and width 
 
brap-2(ok1492) mutants exhibit a significant reduction in (A) body length and (B) body width 
compared to the wild type (N2). (C) Representative images comparing one day old N2 and brap-
2(ok1492) mutant animals. Worms were visualized with DIC and total worm length and width 
was measured [from the anterior-most portion (head) to the posterior tail] using Zen Lite 2010 
Software. Results represent N= 30-40 worms per genotype. p<0.001***.   
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Figure 3.5: brap-2(ok1492) causes a developmental delay and reduced survival  
 
 (A) After 3 days only 9.9% of brap-2(ok1492) worms reach adulthood compared to 72.3% in 
the wild type (N2). Only 63% of brap-2(ok1492) worms reach adulthood after (B) 4 days, 
compared to N2 at 20°C, resulting in a developmental delay of ~24 hours. Development and 
larval stages reached were scored each day for 4 days. Results represent 4 independent trials.  
(C) brap-2(ok1492) experiences a mean survival of 11.67 ± 1.67 days compared to the wild type 
N2 of 13.3 ± 0.67 days. Graph represents one of 3 independent trials. p<0.001***, p<0.01**, 
p<0.05*. 
 
 
3.4.3 BRAP-2 is required for brood size and germline development 
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The growth rate for C. elegans changes with temperature and next we examined brood 
size and embryonic lethality in brap-2 mutants at three temperatures: 16°C, 20ºC and 25ºC. At 
all 3 temperatures, brap-2(ok1492) mutants displayed a 50% decrease in brood size compared to 
the wild type (Figure 3.6). Over 5 days of adulthood, in brap-2 mutants we found brood size to 
be most significantly reduced on the second day of adulthood (Figure S3.1). While embryonic 
lethality appeared elevated in brap-2 mutants at 20ºC, it was observed to be most significantly 
increased at 16°C (Figure 3.6A,B). At 20°C, brood size in worms heterozygous for brap-2 [brap-
2(ok1492)/+] was similar to the wild type yet the presence of one ok1492 mutant allele was 
sufficient to elevate embryonic lethality (Figure 3.6E).  
Having observed an overall reduction in brood size and elevated embryonic lethality, we 
examined brap-2(ok1492) mutant germlines for the presence of any abnormalities. Similar to the 
overall decrease in body size, when we measured gonad length in brap-2(ok1492) mutants they 
displayed a 100 µm decrease compared to the wild type (Figure S3.2). Dissecting intact 
germlines of brap-2(ok1492) mutants followed by DAPI staining, revealed that brap-2 mutants 
exhibited shortened mitotic and transition zones compared to the wild type (Figure 3.7). When 
we scored the number of nuclei diameters from the distal tip of the mitotic zone (MZ) to the 
beginning of the transition zone (TZ), we saw a more significant reduction at 0 Gy in brap-2 
mutants with an average of 16 mitotic nuclei compared to 23 in the wild type (Figure 3.8A,C).  
This suggests that brap-2 mutants may have reduced number of germline progenitor cells 
in the MZ. Specifically, we found brap-2 mutants display similar numbers of germline nuclei in 
all zones except the MZ, with a 50% reduction at 0 Gy and only a 20% reduction at 60 Gy 
(Figure 3.8B). This reduction in the number of mitotic nuclei may contribute to the 20% 
reduction in total germ cell number we observed previously in brap-2 mutants. Interestingly, in 
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addition to finding that brap-2 mutants display similar distribution of germline nuclei over 
surface area compared to the wild type, we also found that brap-2 mutants displayed an increase 
in mitotically arrested nuclei, which may contribute to this reduction in cells in the MZ due to an 
interruption in cell cycle progression.  
Previous work from our lab found that the levels of CKI-1 (p21 ortholog) in vivo in brap-
2 mutants increased in seam cells of the hypodermis, cells responsible for growth and 
development (17). Using qRT-PCR, we measured the mRNA levels of the cyclin dependent 
kinase inhibitors cki-1 and cki-2 (p27 ortholog), and found that they increased 2-fold in brap-2 
mutants (Figure 3.9A) (29). We also found that the G2 mitotic phase arrest associated gene cyb-1 
(Cyclin B1 ortholog) also increased 2-fold in brap-2(ok1492) (Figure 3.9B) (30). Interestingly, 
increased expression of all these genes in brap-2 mutants was dependent on BRC-1 (Figure 
3.9B). This indicates that there may be an increase in cell cycle arrest in the MZ, which may 
contribute to the increased mitotic arrest and reduction of mitotic cells in brap-2 mutants. Taken 
together these results suggest that BRAP-2 is required for normal brood size, embryonic 
survival, as well as proper germline development.  
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Figure caption on next page.  
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Figure 3.6: Brood size is reduced in brap-2(ok1492) mutants  
 
Brood size and embryonic lethality (%) were scored at (A) 16°C (B) 20ºC and (C) 25ºC. At all 
temperatures, brap-2(ok1492) mutants displayed a 50% reduction in brood size compared to the 
wild type (N2). Elevated embryonic lethality was also observed in brap-2(ok1492), except at 
25°C. At 20ºC, brc-1(tm1145) was used a positive control for embryonic lethality. (B) Brood 
size in worms heterozygous for brap-2 [brap-2(ok1492)/+] is not affected. However, the 
presence of one ok1492 mutant allele was sufficient to elevate embryonic lethality. Results 
represent 3 independent trials. p<0.001***, p<0.05*. 
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Figure 3.7: brap-2 mutants exhibit reduced gonad length and a shortened mitotic zone 
 
Representative images comparing DAPI-stained extruded wild type (N2) germline nuclei 
progression to that of brap-2(ok1492) mutants. Z-stack images were taken. Due to the large size, 
images presented are a composite of two images taken at of the same gonad. N=10 per genotype. 
Asterisk indicates the distal tip. PCD (Programmed Cell Death) labels the loop region of the 
gonad were apoptosis occurs.  
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Figure 3.8: brap-2(ok1492) reduces the number of nuclei to the transition zone 
 
(A) The number of nuclei diameters [scored from the distal tip of the mitotic zone (MZ) to the 
beginning of the transition zone (TZ)] are reduced in brap-2 mutants before and after IR.         
(B) brap-2(ok1492) mutants displayed a more significant reduction in the number of mitotic 
nuclei in the MZ at 0 Gy, than at 60 Gy. (C) Representative images of the MZ for each genotype. 
Rows of nuclei were manually counted in whole worms stained with DAPI from the distal tip 
(marked by asterisk) to the beginning of the TZ (marked by the dotted line). White number 
represents the average length of the mitotic zone in nuclear diameters from the distal tip of the 
germline to the TZ. Whole worms were fixed and stained with DAPI. Z-stack images were taken. 
Nuclei of the MZ were counted from one slice of the Z-stack using ImageJ. Results represent N= 
15-40 worms per genotype. p<0.001***, p<0.01**, p<0.05*. 
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Figure 3.9: brap-2(ok1492) mutants display increased mRNA levels of cki-1/2 and cyb-1  
 
Using qRT-PCR, mRNA levels of (A) cki-1 and cki-2, as well as (B) cyb-1 were quantified. 
Levels of cki-1, cki-2, and cyb-1 (one day old adults) all increased 2-fold with a loss of brap-2. 
Results represent 3 independent trials, normalized to act-1 of N2. p<0.001***, p<0.01**, 
p<0.05*. 
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3.4.4 brap-2 mutants possess increased mitotic radiation sensitivity and chromosomal 
abnormalities 
 Having determined that BRAP-2 is required for DNA damage induced germline 
apoptosis in brc-1 mutants, and detected BRAP-2 expression in the germline we asked whether 
BRAP-2 like BRC-1 is involved in DNA repair. To test this, we assessed whether brap-2 
mutants are sensitive to DNA damage using two radiation sensitivity survival assays (9,22). 
First, sensitivity of meiotic pachytene nuclei was determined by scoring lethality of the progeny 
produced by L4 stage animals subjected to DNA damage. Following increasing does of IR, brap-
2 mutants displayed similar sensitivity to DNA damage to that of the wild type (Figure 3.10A). 
We next examined the sensitivity of mitotic nuclei by scoring embryonic lethality of progeny 
produced by adult animals that were irradiated at the L1 stage. We found that brap-2(ok1492) 
mutants displayed a 20% increase in embryonic lethality following IR (Figure 3.10B). This 
indicates that BRAP-2 may be necessary to protect mitotic nuclei from DNA damage, but is 
dispensable for nuclei at the pachytene stage.  
Following late pachytene, nuclei exit the loop region and move on to complete 
gametogenesis to become large oocytes arresting in diakinesis. Wild type oocytes possess 6 
condensed bivalents, representing pairs of homologous chromosomes held together by 
chiasmata, the physical manifestation of DNA cross-over recombination (7). We scored the 
number of bivalents in brap-2(ok1492) oocytes and found that they possessed a similar number 
of bivalents to the wild type. However, following IR brap-2 mutants exhibited a small increase 
in nuclei with greater than 6 bivalents compared to the wild type (Figure 3.11A). Overall, while 
examining the oocytes in brap-2(ok1492) mutants we also observed that approximately 30% of 
oocytes displayed chromosomes that appeared in very close proximity to each other or 
“aggregated”, making it more difficult to score (Figure 3.11B). These results indicate that 
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BRAP-2 may be required to protect germline integrity, as a loss of brap-2 increases mitotic 
nuclei sensitivity to radiation and the appearance of abnormal oocyte chromosome morphology.   
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Figure 3.10: brap-2(ok1492) mutants are hypersensitive to IR during larval development  
 
(A) At increasing doses of IR, embryonic lethality in brap-2(ok1492) mutants is similar to the 
wild type (N2), suggesting that a loss of brap-2 does not affect radiation sensitivity of pachytene 
nuclei. Results represent 3-6 independent trials. (B) An increase in embryonic lethality of 
progeny arising from mitotic nuclei is observed with the loss of brap-2 indicating that BRAP-2 is 
required by mitotic nuclei to resist DNA damage. Results represent 3 independent trials. 
p<0.001***, p<0.01**, p<0.05*. 
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Figure 3.11: brap-2(ok1492) mutants display abnormal chromosome phenotypes 
 
(A) We observed that brap-2 mutants possess a small proportion of oocytes with greater than 6 
bivalents before and after DNA damage (60 Gy) compared to the wild type (N2). (B) brap-
2(ok1492) mutants also displayed oocytes that appeared aggregated or abnormal compared to 
N2. Representative images of N2 and brap-2(ok1492) diakinesis nuclei. Z-stack images were 
taken, where N= 40 oocytes per genotype. The number of DAPI bodies were counted manually 
in -1 and -2 position oocytes at the proximal end of the gonad using Zen 2010 Lite Software.  
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3.4.5 Loss of BRAP-2 reduces sperm quality  
Previously, it was determined that BRAP2 is a binding protein for testis specific proteins 
and binds to PHLPP1 during spermatogenesis (31,4). Since we found the expression of BRAP-2 
in both female and male portions of the germline to be conserved, this led us to hypothesize that 
a loss of BRAP-2 may decrease sperm efficiency and their capacity for fertilization, contributing 
to the reduction in brood size observed in brap-2(ok1492) mutants.  
The incidence of males in the C. elegans population occurs at a frequency of 0.01 to 
0.1% and is attributed to the spontaneous non-disjunction of sex chromosomes during meiosis 
(5). However, a mutation known as “high incidence of males” (HIM) significantly increases 
embryonic lethality and increases the frequency of males and XXX hermaphrodites due to a 
reduction in the number of crossovers and defective segregation of the X chromosome (32,33). 
Unlike brc-1 mutants, that display both increased embryonic lethality and increased male 
progeny, brap-2(ok1492) mutants do not display an increase in the number of males. To test the 
effect brap-2(ok1492) has on the frequency of males produced by him-5 mutants, we generated a 
brap-2(ok1492);him-5(e1490) double mutant strain. While embryonic lethality was not 
significantly affected, we found that compared to single him-5 mutants, a loss of brap-2 reduced 
brood size by half (Figure 3.12A), reduced XXX progeny (identified due to their “dumpy” 
phenotype) and reduced the incidence of males by 15% (Figure 3.12B,C).  
Sex is determined by a XX/XO system, thus when a male worm mates with a 
hermaphrodite, male sperm will outcompete hermaphrodite sperm and approximately 50% of 
progeny produced by this mating are expected to be male (34). To determine the quality (ability 
to fertilize oocytes) of brap-2(ok1492) mutant sperm, three young brap-2;him-5 males were 
mated with one virgin L4 wild type hermaphrodite. We found that brap-2(ok1492);him-5(e1490) 
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males produced a modest decrease of 13% less male progeny and thus were partly less able to 
outcompete hermaphrodite sperm (Figure 3.12E). Males have nine paired sensory rays along 
their hooked tail that allows them to search for and penetrate the hermaphrodite vulva for sperm 
transfer and fertilization (34). Although we did not observe a difference in the number of sensory 
rays (Table S3.1), we did observe qualitatively that similar to brap-2 hermaphrodites, brap-
2;him-5 mutant males compared to single him-5 mutants appeared smaller in size, and their tails 
and the morphology of their sensory rays appeared slightly smaller and shorter, respectively 
(Figure S3.3). These results indicate that BRAP-2 may play a role for proper development of 
sperm and may in part reduce X chromosome mis-segregation in him-5 mutants.  
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Figure 3.12: brap-2(ok1492) decreases sperm quality  
(A) brap-2(ok1492) mutants decreased brood size in him-5 mutants by 50%. (B) A loss of brap-2 
reduced embryonic lethality but not significantly in him-5 mutants. (C) Male progeny (%) in 
him-5(e1490) was reduced by 15 % with a loss of brap-2. (D) XXX progeny was significantly 
reduced in him-5(e1490) mutants with a loss of brap-2. (C) brap-2;him-5 males were less able to 
outcompete hermaphrodite sperm and produced an average of 12% less male progeny. On the x-
axis, “N2 x him-5” and “N2 x him-5;brap-2” represent matings set up between a virgin wild type 
hermaphrodite and 3 male worms. Results represent 3 independent trials. p<0.01**, p<0.05*. 
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3.5 Discussion 
Here we have shown that brap-2 mutant animals are shorter in length and width, possess 
a 24 hour developmental delay to adulthood and exhibit a reduced mean survival compared to 
the wild type. We previously determined that brap-2(ok1492) mutants are dauer defective and 
unable to enter developmental arrest in response to starvation due to increased DAF-2/Insulin-
like signaling and attenuation of DAF-16 (FOXO ortholog). In C. elegans, SKN-1/Nrf2 
activation contributes to increased lifespan (35). A mutation in daf-2 (IGF1 ortholog) 
significantly increases C. elegans lifespan due to DAF-16 activation (27). We have previously 
found that brap-2 mutants display increased SKN-1 activity (18). This contradiction wherein 
brap-2 mutants experience a reduction in mean survival, while possibly possessing over 
activation of SKN-1, may be due in part to the potential increase in IIS and DAF-16 inhibition 
occurring in parallel. At the same time, a loss of brap-2 may influence several others pathways 
which converge and have an overall negative affect on lifespan.  
We have shown that BRAP-2 expression is conserved and localized to the cytoplasm of 
the wild type hermaphrodite germline surrounding germline nuclei. Using CRISPR-Cas9, we 
were able to confirm BRAP-2 expression in both the meiotic and somatic (sperm sac, uterus) 
portions of the germline in vivo. Expression of BRAP-2 in the germline suggests that it may be 
required for its proper development and preservation of genetic integrity. First, we found that 
brap-2 mutants displayed a 50% reduction in brood size across three different temperatures. 
However, in a strain heterozygous for brap-2(ok1492) one wild type brap-2 allele was able to 
restore brood size to levels more similar to the wild type. Due to the overall reduction in body 
size in brap-2 mutants, we expected and observed a reduction in gonad length. Although brap-2 
mutant germlines were shorter, we previously determined that the number of nuclei per surface 
138 
 
area were similar to the wild type. We also found that brap-2 mutants exhibit a significant 
reduction of nuclei in the MZ, as well as a reduction in the number of nuclei diameters from the 
distal tip of the MZ to the TZ, indicating that entry in the TZ may occur earlier in brap-2 
mutants.  
Age-related loss of mitotic nuclei has been observed in aging worms and has been 
associated with defective mitotic cell cycle arrest, a decrease in mitotic index and IIS pathway 
activation, where elimination of IIS through daf-2 knockdown or mutation elevated the number 
of stem cell progenitors in these older worms (36). We previously observed that brap-2(ok1492) 
mutants display enhanced mitotic arrest and potential attenuation of DAF-16, a downstream 
target of the IIS pathway. In addition, we observed a 2-fold increased expression of cycle arrest 
associated genes cki-1, cki-2 and cyb-1 in brap-2 mutants. It is possible that enhanced IIS and 
robust mitotic arrest could contribute to the reduction of mitotic nuclei in brap-2 mutant 
germlines, as well as contribute to their reduction in brood size. However, it is also possible that 
a loss of brap-2 adversely affects other pathways that control meiotic progression, or entry of 
pachytene nuclei into oogenesis such as the LET-60/MPK-1 (Ras/ERK orthologs) pathway that 
could decrease oocyte production and therefore lead to an overall reduction in brood size.  
DNA repair mutants like brc-1, tend to display higher levels of embryonic lethality due to 
an accumulation of unrepaired DSBs induced during recombination (9). Although not as high as 
brc-1 mutants, brap-2 mutants also display elevated levels of embryonic lethality. After testing 
the radiation sensitivity of mitotic and pachytene nuclei, we found that a loss of brap-2 reduced 
the resistance of only mitotic nuclei to IR. So far it has been observed that DDR mutants tend to 
increase damage sensitivity in either mitotic or pachytene nuclei, not both, a trend consistent in 
brap-2 mutants, indicating it may be involved in DNA repair (9). However, further work such as 
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examining RAD-51 foci formation following DNA damage and careful classification of 
chromosome abnormalities, as well as how they can be rescued is required to determine if 
BRAP-2 is involved in facilitating DNA repair or if a loss of brap-2 produces these defects 
indirectly, by affecting the proteins or pathways involved in DNA repair or the conformational 
changes and packaging of chromosomes prior to fertilization (37).  
BRAP2 is conserved in the model flowering plant Arabidopsis thaliana which possesses 
conserved RING domain BRAP2 protein homologs BRIZ1 and BRIZ2 (BRAP2 RING ZnF-UBP 
domain-containing protein) that dimerize and exhibit conserved functional E3 ubiquitin ligase 
activity, that is required for seed germination and growth (38). BRAP2 was also found to be 
highly expressed in mouse testis, acting as a potential scaffold protein for the AKT protein 
phosphatase PHLPP1 during sperm maturation (4). Since we previously confirmed the conserved 
interaction between PHLP-2 (PHLPP1/2 ortholog) and BRAP-2, and observed conserved 
expression of BRAP-2 in the sperm sac, we examined the affect a loss of brap-2 has on sperm 
quality and determined if it is genetically linked to him-5, a mutation that increases male 
production (32). We found that a loss of brap-2 modestly reduced the number of males in him-5 
mutants and that brap-2 mutant males were less able to outcompete hermaphrodite sperm, 
producing a modest reduction in male progeny. Although further work is required, these initial 
studies indicate that BRAP-2 may in part be required for the production of males in him-5 
mutants and may also play a potential conserved functional role in proper sperm maturation that 
affects their capacity for fertilization.  
 Here we have uncovered a novel role for BRAP-2 in C. elegans and have found that it is 
required for normal morphology, development and survival. We also determined that BRAP-2 is 
involved in germline development and protection where its loss compromises brood size, 
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embryonic viability, and affects germline development and morphology. Particularly, we found 
that BRAP-2 is required for the health and protection of the mitotic progenitor stem cell pool. 
However, although we have uncovered a potential novel role for BRAP-2 further investigation is 
required to determine the mechanisms through which BRAP-2 may regulate meiotic germline 
development, DNA repair, as well as other possible signaling cascades such as the Sma/Mab 
TGF-β (Small/Male Abnormal Transforming Growth Factor β) pathway that governs C. elegans 
development and worm size (39,40). 
Protection of genomic integrity in the germline from both endogenous and exogenous 
stressors is essential, as DNA damage left unfaithfully repaired can lead to an accumulation of 
mutations, abnormal cells, compromised gametes, dysfunction and disease (41). Although it is 
unknown whether BRAP2 is directly involved in regulating development, DNA repair or 
meiosis, due to BRAP-2’s high genetic, functional and tissue expression conservation to its 
mammalian counterpart, this work can be used as a starting point to determine whether the role 
of BRAP-2 in C. elegans morphology, development, survival and germline health is conserved in 
higher organisms. 
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3.6 Supplementary Figures  
 
 
 
 
 
Figure S3.1: Brood size per day in brap-2 mutant adults is reduced  
 
Compared to the wild type (N2), the number of progeny (brood size) was scored over 5 days of 
and was found to be significantly reduced in brap-2(ok1492) mutants on the second day of 
adulthood by 60%. The number of progeny was scored each day for 5 worms placed individually 
on NGM plates. Results represent 3 independent trials. p<0.001***.  
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Figure S3.2: Gonad length is reduced in brap-2 mutants  
 
brap-2 mutants exhibit a reduction in gonad length compared to the wild type (N2). One day old 
adult worms were fixed and stained with DAPI and images of whole worms were taken for 
analyses. The line measurement tool in Zen 2010 Software was used to measure the length of 
one gonad per worm from the distal tip to terminal oocyte at the -1 position. Results represent 
N= 50 per genotype. p<0.001***.   
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Table S3.1: Number of sensory rays in him-5 and brap-2;him-5 mutants  
With a loss of brap-2, the number of sensory rays was not significantly different to single him-5 
mutant males. Numbers represent the number of rays on one side of the male tail fan. DIC 
images of young males for each genotype were taken and counted manually in Zen 2010 Lite 
software.  
 
 
  Number of Sensory Rays (%) 
Strain N 9 8 7 
him-5(e1490) 49 93.88 4.08 2.04 
brap-2(ok1492);him-5(e1490) 56 89.29 10.71 0 
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Figure S3.3: Morphology of male sensory rays is altered in brap-2 mutants  
Representative images of young him-5(e1490) and brap-2(ok1492);him-5(e1490) males. While a 
loss of brap-2 did not alter the number of sensory rays in him-5 mutants, we observed that a 
small proportion of brap-2;him-5 mutant males were smaller in size and displayed shorter 
sensory rays as seen in the top panel. Z-stack images were taken and rays were counted manually 
in Zen Lite 2010 Software. Black numbers on bottom panel label the sensory rays on one half of 
each male tail fan. N=49 for him-5(e1490) and N=56 for brap-2(ok1492);him-5(e1490).  
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Chapter 4 
General Discussion and Future Directions 
 
4.1 Summary  
 
The objective of this study was to characterize the role of BRAP-2 in the DDR and 
determine its importance in C. elegans survival and development. In this study, we have 
identified the potential mechanism through which BRAP-2 promotes DNA damage induced 
germline apoptosis and shown that BRAP-2 is required for normal C. elegans morphology and 
development. We have (i) identified brap-2 as a DNA damage response gene; (ii) determined 
BRAP-2 specifically promotes DNA damage induced germline apoptosis through the regulation 
of SKN-1 through p38 MAPK/PMK-1 and IIS pro-survival pathways, and (iii) shown that 
BRAP-2 is required for C. elegans survival, development and germline health.  
4.2 Identification of BRAP-2 as a DNA damage response gene and regulator of the SKN-
1/PMK-1 and IIS pathways reinforces the “intestine to germline” interaction during stress 
 
 Our lab focused its interest on BRAP2/IMP, a BRCA1 binding protein and cytoplasmic 
retention protein involved in cell signaling pathway regulation (1). Using C. elegans as a model, 
our lab first identified a genetic interaction between BRAP-2 and BRC-1 during oxidative stress 
(2). Study of BRAP-2 in the oxidative stress response continued and it was determined that a loss 
of brap-2 increased SKN-1/Nrf2 nuclear accumulation, and significantly increased the 
expression of SKN-1 target genes (3). This revealed a novel role for BRAP-2 as a possible 
negative regulator of SKN-1, a primary activator of the C. elegans phase II detoxification 
response whose function is localized to the intestine (major detoxification organ) for protection 
against stress, and within neurons to influence longevity (4).    
Since BRCA1 and its function in DNA HR repair is conserved in C. elegans, in this study 
we sought to further explore the genetic interaction between brap-2 and brc-1 in response to 
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DNA damage and determine whether BRAP-2 is a potential DDR gene. Using the C. elegans 
germline as an experimental system, the work conducted here provides the first evidence of a 
role for BRAP-2 in the DDR, where it is required to specifically promote DNA damage induced 
germline apoptosis and is required for high levels of germline apoptosis incurred by a loss of 
brc-1. We determined that BRAP-2 is required to promote apoptosis in response to IR and that it 
does so by regulating pathways parallel to the CEP-1 core apoptotic program.  
The RAS signaling pathway and p38 MAPK have been implicated in the regulation of 
apoptosis, and this is conserved in C. elegans. MPK-1 is required for germline progression and 
activation of CEP-1 (5), while PMK-1/p38 MAPK function has been linked to germline 
apoptosis induced by arsenite exposure, bacterial infection and IR (6). Having observed 
increased SKN-1 activation in brap-2 mutants, we found that skn-1 RNAi knockdown decreased 
pro-apoptotic gene expression, but only elevated apoptosis in brap-2;brc-1 double mutants. We 
also determined that activity of the SKN-1 activator PMK-1 is elevated in brap-2 mutants.  
Previously, in response to IR, pmk-1(km25) mutants were found to display reduced levels 
of apoptosis compared to the wild type (7). However, in this study we observed that pmk-1 
mutants produced similar levels of apoptosis to the wild type and increased apoptosis in brap-2 
mutants, while a loss of mpk-1 did not. We found that the loss of mpk-1 or pmk-1 both decreased 
the expression of pro-apoptotic CEP-1 target genes egl-1 and ced-13. However, in brap-2 
mutants increased egl-1 expression levels were dependent on CEP-1 and MPK-1. This suggests 
that the reduction in germline apoptosis caused by a loss of brap-2 is dependent on PMK-1, but 
pro-apoptotic egl-1 expression in this context may be dependent on increased MPK-1 activation 
of CEP-1. Although complex, activated PMK-1 observed with a loss of brap-2 may function 
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either independently or through the downstream activation of SKN-1 to induce the transcription 
of genes that prolong cellular health and survival to antagonize CEP-1 activity. 
A Y2H screen using a human testis cDNA library has identified novel BRAP2 protein 
binding candidates (8,9). In addition to the validation of BRAP2 interacting with testis specific 
proteins, Fatima et al. (2015) confirmed BRAP2 interactions with three additional proteins, 
including the AKT protein phosphatase PHLPP1. We identified that this interaction is conserved 
in C. elegans and we further postulated that BRAP-2 may act as a potential regulator of AKT-1, 
and its downstream target DAF-16. We determined that not only does a loss of brap-2 elevate 
PMK-1 activity, it increases AKT-1 protein levels and may also cause increased IIS activation.  
Although we were not able to test for levels of phosphorylated AKT-1 in brap-2 mutants 
to confirm elevated AKT-1 activity as a marker for IIS activation, we believe that (i) the inability 
of brap-2 mutants to enter dauer, (ii) reduced DAF-16 intestinal nuclear accumulation, and (iii) 
reduced DAF-16 target gene expression indicates elevated IIS and partial attenuation of DAF-16. 
We also saw that a loss of akt-1 more significantly restored apoptosis to wild type levels than 
akt-2 in brap-2 mutants, suggesting the potential for AKT-1 activation promoting cell survival in 
the absence of brap-2. At the same time, we also uncovered a possible new role for PHLP-2 as 
being required for the general activation of apoptosis.  
Extensive research has shown that the choice for cell survival and homeostasis is 
governed by many pathways that respond differently, depending on stress and cell type as well as 
severity. The interpretation of these stimuli, and the subsequent outputs of stress signaling and 
repair pathways are dependent on one another, and eventually can all influence the balance 
between pro-apoptotic and anti-apoptotic factors that decide the fate of a cell. Taken together, in 
addition to regulation of SKN-1/Nrf2 and PMK-1/p38 MAPK, we have determined that BRAP-2 
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is also a potential regulator of the IIS pathway, a major regulator of C. elegans development, 
longevity and developmental arrest, whose function is also localized to the intestine. This 
indicates that BRAP-2 may act as an anchor, linking the intestine and germline for parallel 
regulation and potential cross talk of these pathways in response to stress that converge and 
influence cell survival or death decisions. When BRAP-2 is lost, it may tip the balance of these 
signals toward cell survival and evasion of cell death in the germline, simulating a hallmark of 
cancer.  
4.3 Identification of BRAP-2 as a regulator of stress response pathways revealed its 
importance in C. elegans development, survival and germline health.  
 
 Working with brap-2 mutant animals, qualitatively we observed that they were shorter 
and grew more slowly compared to the wild type. Our identification of the involvement of 
BRAP-2 in regulating DNA damage induced germline apoptosis, as well as IIS and SKN-1/Nrf2 
pathways which are known to regulate oxidative stress, longevity and worm development 
prompted us to further examine the effects that a loss a BRAP-2 has on the worm overall. We 
found that in addition to the inability for brap-2 mutants to enter dauer, worms are shorter, have 
reduced mean survival, a reduction in brood size and delayed development.  
The conserved expression of BRAP-2 in germline tissue led us to further inspect the 
germline in brap-2 mutant animals and we found that a loss of brap-2 modestly reduced the 
ability for sperm to outcompete and fertilize oocytes, while also reducing the number of males 
produced in him-5 mutants. We also determined that BRAP-2 may be specifically needed to 
protect the mitotic germ cell population from DNA damage. Since shortcomings in several 
aspects of worm development were observed, it demonstrates that a diverse array of detrimental 
effects can be caused by pathway mis-regulation incited by a loss of BRAP-2. Phenotypes 
caused by a loss of brap-2 is comparable to other previously identified DDR as well as aging 
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mutants, which can also display defects in C. elegans development, longevity and germline 
protection. Although further work is needed to examine the potential pathways BRAP-2 may 
regulate in this context, we have revealed that a loss of BRAP-2 produces defective phenotypes 
in worm anatomy, development and survival, as well as disrupts germline morphology and 
integrity.  
4.4 Potential future studies for BRAP-2 in C. elegans  
In this study, since BRC-1 is a conserved DNA repair protein that facilitates HR, we 
focused on determining the role of BRAP-2 in the DDR when exposed to IR, which induces 
DSBs and activates HR repair pathways. We did not expose brap-2 mutants to other direct forms 
of DNA damage such as UV and ENU, known to activate other DNA repair pathways such as 
nucleotide excision repair and NHEJ) (10) or indirect forms of damage that may arise from 
exposure to oxidative stress inducers such as paraquat or arsenite (11). It would be interesting to 
determine whether BRAP-2 is necessary or produces a similar resistance to apoptosis through a 
comparable stress response mechanism to different forms of DNA damage, or if it is specific to 
stress caused by DSBs due to its genetic link to BRC-1.  
Our study has demonstrated the expansive influence BRAP-2 has on stress signaling 
cascades involved in detoxification and cell death, as well as on the outcome of C. elegans 
morphology, development and survival. We have also determined that BRAP-2 expression, 
localization and potential function as a binding protein is conserved. BRAP-2 also possesses 
conserved RING and ZnF-UBP domains, suggesting that it may function as E3 ubiquitin ligase. 
However, we did not determine whether BRAP-2 displays intrinsic E3 ligase activity to target 
itself or other proteins it interacts with, such as PHLP-2 for degradation. Ubiquitination allows 
for targeted stabilization and degradation of many proteins as a means for cell signaling 
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regulation and feedback loops (12). RING-type E3 ubiquitin ligases transfer ubiquitin (Ub) from 
E2-Ub (Ubiquitin conjugating enzymes) to target substrates (13), and in C. elegans 20 ubiquitin 
conjugating enzymes (UBCs) have been identified (14). It will be important to determine if 
BRAP-2 binds to any of the conserved UBCs, and verify whether BRAP-2 elicits this enzymatic 
activity for the potential ubiquitination of its targets as a means of regulating oxidative stress and 
DDR pathways other than by acting as a general binding protein.  
  We have shown that brap-2 mutants exhibit defects in development, morphological 
abnormalities in overall anatomy and within the germline. The IIS pathway is primarily involved 
in the regulation of lifespan, developmental arrest and participates in the oxidative stress 
response through DAF-16 activation (15). With these observed defects in brap-2 mutants, and 
BRAP-2 functioning as a potential regulator of the IIS pathway, it hints at a possible regulatory 
role of BRAP-2 in size determination controlled by the Sma/Mab TGF-β pathway (16). The 
effects a mutation in brap-2 has on the MZ in the germline could also associate BRAP-2 with the 
regulation of Notch signaling, localized at the distal tip cell of the germline and functions to 
renew mitotic stem cells (17). Due to their extensive downstream reach and control of several 
substrates, there is a possibility that the morphological, developmental and survival defects seen 
in brap-2 mutants are a by-product of the dysregulation of the pathways regulated by BRAP-2. 
However, it would be interesting to explore the potential involvement of BRAP-2 as a regulator 
of pathways that are not necessarily associated with stress responses, and if BRAP-2 acts as a 
bridge between them.  
One of the ways in which we can further illuminate the role of BRAP-2 in C. elegans is 
using the BRAP-2::GFP transgenic strain generated in this study. An interaction network for 
BRAP-2 can be built using this strain to conduct mass spectrometry and proteomics to identify 
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novel protein candidates for BRAP-2 (18,19). Using this high throughput approach, it may reveal 
novel interactions and pathways that BRAP-2 may be part of which may or may not mimic its 
mammalian counterpart. In this way, it will establish a more comprehensive view of the role of 
BRAP-2 in C. elegans.  
4.5 Future studies of BRAP2 should focus on the biological significance of its predicted 
interactions and potential conserved role in the DNA damage response  
 
 Due to the high expression of BRAP2 in mammalian testes, a testis-specific human 
cDNA Y2H screen produced a list of 30 candidate proteins that BRAP2 is predicted to interact 
with (8,9). While these studies have validated a few candidates and reinforced the idea that 
BRAP2 acts as a general cytoplasmic retention protein seen with its interaction several proteins 
including PHLPP1 during spermatogenesis, it will be important to continue the validation of 
other proteins in the screen to help further elucidate the role and influence BRAP2 has on other 
cellular mechanisms. For example, BRAP2 was found to bind to the DNA methyltransferase 
DNMT1, necessary for methylation and implicated in cancer, as tumors display aberrant 
methylation patterns (20). BRAP2 was also predicted to bind to SMARCE1, which encodes one 
subunit of the SWI/SNF chromatin remodeling complex required for transcription (21). This, in 
addition to the ability of BRAP2 to bind to BRCA1, which is an important DNA repair and 
tumour suppressor protein, indicates that BRAP2 may be needed for the maintenance and 
protection of genomic integrity for the prevention of cancer, and thus these BRAP2 interactions 
should be further explored.  
 BRAP2 was also found to be highly expressed in heart tissue (9). A reduction in BRAP2 
expression has been linked to myocardial hypertrophy (22), and BRAP2 polymorphisms have 
been associated with coronary artery disease and metabolic syndromes (23–25). This association 
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with heart disease suggests the importance of conducting a more in depth investigation into the 
role of BRAP2 in cardiovascular health, reveal potential heart specific proteins it may associate 
with as well determine if its role in the regulation of RAS signaling is important in this context. 
Recently, BRAP2 has also been associated with CCDC178 (Coiled-coil domain-containing 
protein 178), that is frequently mutated in hepatocellular carcinoma. CCDC178 promotes 
BRAP2 degradation for increased ERK signaling, and a loss of CCDC178 caused a BRAP2 
dependent inactivation of ERK (26).  
This provides evidence that functional BRAP2 is linked to several disease states, and due 
to the high prevalence of cancer caused by BRCA1 mutations, BRAP2 should also be considered 
as a disease biomarker. However, although BRAP2 is linked to disease we do not know if a 
mutation in BRAP2 will reveal a similar mechanism of p38 MAPK, Nrf2 and AKT pathway 
regulation, or confer resistance to apoptosis in response to IR in the same way as we have 
observed in C. elegans. Due to the high genetic similarity between humans and C. elegans, our 
investigation does provide a basis for future studies to investigate the potential role and 
mechanism of BRAP2 in apoptosis in response to DNA damage, and its potential interaction 
with BRCA1 in this context.   
4.6 Conclusion 
 BRCA1 is a tumor suppressor involved in transcription, cell cycle arrest and apoptosis 
and when its function is lost due to mutation it results in the increased risk of breast and ovarian 
cancer (27). The biological implications of its interaction with BRAP2 have only be inferred, as 
preventing BRCA1 nuclear translocation thereby prohibiting its functions that protect genomic 
integrity (1). This study has uncovered the role of C. elegans BRAP-2, where a mutation in 
BRAP-2 tips the balance towards activating cell survival pathways mediated by SKN-1/Nrf2 and 
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AKT-1/AKT, evading cell death which is necessary for the removal of genetically compromised 
cells. With approximately 40% of human disease genes having a homolog in C. elegans, this 
study reinforces the power of this organism and its germline as a model to study gene function in 
DDR pathways to predict their involvement in diseases such as cancer (28). Although further 
study is needed to determine the clinical importance of BRAP2, the work presented here has 
identified a previously unknown role for BRAP-2 in C. elegans in the regulation of pro-cell 
survival signaling pathways, presenting a potential intestine to germline interaction for the 
regulation of DNA damage induced germline apoptosis. We have also uncovered a role for 
BRAP-2 in C. elegans development and germline health. Studies such as this, illustrate the 
importance of exploring the biological significance of novel proteins involved in physical 
interactions between established disease-related genes such as BRCA1. What may at first appear 
as a simple binding event, may have profound effects and present potential therapeutic targets if 
they influence essential cellular pathways, that when disrupted lead to aberrant signaling, cellular 
disarray and the onset of diseases such as cancer.  
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Table 1: Worm strains used in this study. Strains were obtained from the Caenorhabditis 
Genetics Center (CGC), located at the University of Minnesota and the National Bioresource 
Project in Tokyo, Japan. Double mutant stains were generated using standard protocols and 
genotypes were verified using SW-PCR were applicable.  
 
Strain Genotype 
CF1038 daf-16(mu86) I 
CF1139 daf-16(mu86) I; muIs61 
DR466 him-5(e1490) V 
DW102 brc-1(tm1145) III 
KU25 pmk-1(km25) IV 
MD701 bcIs39 V [lim-7p::ced-1::GFP + lin-15(+)] 
PD9927 ced-9(n2812) III/hT2 [bli-4(e937) let-?(q782) qIs48] (I;III); nIs106 X 
SD939 mpk-1(ga111) unc-79(e1068) III 
VC204 akt-2(ok393) X 
YF104 brap-2(ok1492)/mIn 1 [MIs14dyp10 (e128)] II 
YF15 brap-2(ok1492) II  backcrossed 3X  
YF179 brap-2(ok1492) II; ced-9(n2812) III/hT2 [bli-4(e937) let-?(q782) 
qIs48] (I;III); nIs106 X 
YF180 brap-2(ok1492); bcIs39 [lim-7p::ced-1::GFP + lin-15(+)] V 
YF186 akt-1(ok525) V; brap-2(ok1492) II 
YF188 akt-2(ok393) X; brap-2(ok1492) I 
 
YF189 brc-1(tm1145) III; daf-16(mu86) I 
YF19 brap-2(ok1492) II; daf-16(mu86) I 
YF190 brap-2(ok1492) II; daf-16(mu86) I; muIs61 
YF191 brap-2(ok1492) II; phlp-2(tm7788) III 
YF192 akt-1(ok525) V; phlp-2(tm7788) II 
YF193 brc-1(tm1145) III; phlp-2 (tm7788) III 
YF195 brap-2(ok1492) II; him-5(e1490) V 
YF197 brap-2(ok1492) II; pmk-1(km25) IV 
187 
 
YF198 akt-1(ok525) V 
YF199 BRAP-2::GFP 
YF200 phlp-2(tm7788) III 
YF62 cep-1(gk138) I 
YF63 brap-2(ok1492) II; cep-1(gk138) I 
YF64 brap-2(ok1492) II; brc-1(tm1145) III 
YF94 brap-2(ok1492) II; mpk-1(ga111) unc-79(e1068) III 
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Table 2: Forward and reverse primers for SW-PCR  
 
Gene  Allele Name Tm (ºC) Sequence  
akt-1 ok525 TK40 
TK41 
TK42 
64.0 
63.6 
63.8 
F: TATTGCTGACACCAGCGAAG 
R: TCGTTGTCTTCACTTGCTTCA 
F: ATTCGGATTTTCCCCAAGTC 
akt-2 ok393 TK56 
TK57 
TK58 
69.5 
70.1 
63.8 
F: CGGCAGTACACAGAGTGTGAT 
R: CTCGTGTCCGTTTCAGACATCACAT 
F: GAGAGGGGTTATCACAACTTGAAG 
brap-2  
 
 
 
ok1492 olok14925 
ok14923B 
ok14925 
ok1492N23 
 
66.8 
62.3 
62.5 
61.1 
 
F: GTCAGCACCGAAAATGTGTCAG 
R: CAGACAACGTCGAATGATCTC 
F: GAGTGTATTCGAGTTTGATTCCC 
R: TTTGTTCTGCCTAGGAATAAGTG 
 
brc-1 tm1145 brc-1N2For 
brc-1 For 
brc-1 Rev 
65.0 
61.3 
60.3 
F: AGAACCAGCCACAAAACAACC 
F: GTTCAATGCCCAATTTGTAGA 
R: CTAGTTTTTGGATTGGCTCAG 
cep-1 gk138 cep-1 For 
cep-1 N2 For 
cep-1Rev 
70.0 
62.3 
58.1 
F: GAAATTGTCCCGTTCCCGTGA 
F: TAGGGGGTGGTGTAAGAGAAA 
R: GTACAGCGACTTCTCTTCATC 
*daf-16 mu86 MAM8 
MAM9 
MAM7 
 
57.5 
59.5 
61.2 
 
F: CTAGGAGGAAAAGCCATTTGT 
F: CCAATAGCTGGAGAAACACGA 
R: CGGTGACCATCTAGAGTCACA 
 
phlp-2 tm7788 TK21 
TK22 
59.7 
58.4 
F: CTGTCCTCACTTCCCAAAC 
R: TCACCATAGGCACGCTTGTA 
pmk-1 km25 pmk1N2For 
pmk1For 
pmk1Rev 
60.3 
60.3 
58.4 
F: CTGTTTGGTATGTCATTTCAACTG 
F: CAATCGATCTCAGATGTTCTTTTC 
R: CAGAATCAGTTTGACGTGCC 
 
* Love et al.2010. PNAS Apr 20; 107(16):7413-8. doi: 10.1073/pnas.0911857107. 
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Table 3: Forward and reverse primers for qRT-PCR 
 
Name  Tm (ºc) Sequence 
act-1 63.9 
64.1 
F: GTCGGTATGGGACAGAAGGA 
R: GCTTCAGTGAGGAGGACTGG 
akt-1 58.4 
60.5 
F: CCCGAAGATGCATTGGAGAT 
R: GCTTCTACTAGGCGGTGTCA 
ced-9 64.0 
63.8 
F: AAATGATGGAATCCGTGGAA 
R: CCCACTTTTTCAGCTTCTGC 
ced-13 65.2 
62.6 
F: ACGGTGTTTGAGTTGCAAGC 
R: GTCGTACAAGCGTGATGGAT 
cki-1 61.09 
60.53 
F: CCCAAGCTCTGCTGGATTCG 
R: GTTGGGATCCATCAGCGAGG 
cki-2  63.7 
63.8 
F: ACCCGATCCAGAAGAGGTTT 
R: CTTCGGAAGCAGAAATCGAC 
ctl-1 68.4 
65.0  
F: GTGTCGTTCATGCCAAGGGA 
R: CCCAGTTACCCTCCTCGGTA 
cyb-1 59.04 
57.51 
F: AAGAACTTCAAACAGGGGAAGC 
R: TTCCATTTCTGATGCGTCCA 
egl-1 63.8 
63.7 
F: TCACCTTTGCCTCAACCTCT 
R: CATCGAAGTCATCGCACATT 
F08G5.6 60.5 
58.4 
F: GTCCCACTGTCACAAGCTCA 
R: GTTTCGACCGAGAAATCGAG 
F35E12.6 54.3 
58.4 
F: ACACAATCATTTGCGATGGA 
R: GGTAGTCATTGGAGCCGAAA 
ins-7 63.4 
64.2 
F: AGGTCCAGCAGAACCAGAAG 
R: GAAGTCGTCGGTGCATTCTT 
skn-1c 66.6 
66.8 
F: TACTCACCGAGCATCCACCA 
R: TGATCAGCAGGAGCCACTTG 
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Table 4: Forward and reverse primers for cloning PHLP-2 into pCMV7.1 3xFLAG 
 
Name Tm (ºc) Sequence 
 
C-terminus 
 
TK9  
 
 
PHLPP13xFLAG
Rev 
 
 
 
N-terminus 
 
TK28 
 
 
TK11 
 
 
 
81.3 
 
 
83.2 
 
 
 
 
 
 
86.2 
 
 
78.7 
 
 
 
F:GGCCGCGAATTCATCGATAGATCTCAATTTAAGTT
CAAACCGCCTGACAAG 
 
R:ACAGGGATGCCACCCGGGATCCTTAAATATTAAAA
GTAACCGTATTAGGAGGGCTCAA 
 
 
 
 
 
F:AGGATGACGATGACAAGCTTGCGGCCGCGATGGCT
CCACTTGGCTACATAG 
 
R:GCGGTTGAACTTAAATTGAGATCTTCCAGAAGCTC
CAAAGAGCTG 
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Table 5: CRISPR-Cas9 primers used to generate BRAP-2::GFP strain 
 
Name Tm (ºc) Sequence 
TK161 
 
75.0 TTCAATTTTCTCGACGAGGGTTTTAGAGC 
TAGAAATAGCAAGT 
brap-2sgRNA 53.0 TTCAATTTTCTCGACGAGG 
5’arm 
TK2 
 
 
TK12 
 
94.0 
 
 
93.6 
 
AGTCACGACGTTGTAAAACGAGGCCAGTCGCCG
GCAGGTGGAGACAAGCTTGAGGG 
 
CATCGATGCTCCTGAGGCTCCCGATGCTCCCAAG
GACTTTTTCTTCTTTCTGTTCAATTTTCTCGACGA
TGATGACGACG 
3’arm  
TK159 
 
 
TK160 
 
83.2 
 
 
79.5 
 
CGTGATTACAAGGATGACGATGACAAGAGATAA
TTGGCATCTCAGGAGATCCATGTCC 
 
GGAAACAGCTATGACCATGTTATCGATTTCCAAA
AATCGATAATCTTGGTTAGTGAGT 
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Table 6: Forward and reverse worm strain sequencing primers used in this study 
 
Name Tm (ºC) Sequence  
him-5 58.3 
72.1 
F: ATGTCCAGAATTCGTTCTAATAAC 
R: GCGCGTTTTTTTGGAATGCGGAATGACCAC 
mpk-1 58.4 
58.4 
F: TCAATGCCTGATGGAGACTG 
R: TCTTGGATCAGCTCCTGGAT 
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Table 7: Antibodies and reagents for Western blot and immunostaining  
 
 
* Whole worm/gonad antibody staining 
 
 
 
Antibody Company Species Dilution/Concentration 
BRAP-2 Toronto 
Recombinant 
Antibody Centre  
Rabbit 1:100 
DAPI Sigma - 1 µg/mL  
DAPI VECTOR - 1 µg/mL 
FLAG-M2 Sigma  Mouse  1:5000 
GAM HRP A555 Invitrogen Mouse 1:1000 
GAR HRP A488 Invitrogen Rabbit 1:1000 
GST Cell Signal Rabbit 1:5000 
AKT-1 127/528 Gift from Dr. Brent 
Derry 
Goat 1:1000 
Phospho-p38 MAPK Cell Signal Rabbit  1:100 
1:1000 
RAD-51 Gift from Dr. Anton 
Gartner  
Rabbit 1:100 
Tubulin Cell Signal Mouse 1:2000 
